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Abstract
Carbon nanotube arrays have been found to be highly effective at carrying out intracellular delivery of
cargo at high efficiencies while ensuring cell viability. Template based chemical vapor deposition is a
commonly used process to fabricate these arrays. However, current etching methods used to expose
carbon nanotubes from templates are expensive and time consuming. The high cost and time-consuming
processes currently required to fabricate such arrays are factors which limit the commercialization of this
technology and inhibit scope for larger research programs. In this thesis, alternative nanofabrication
methods were explored with the aim of making the fabrication of CNT arrays cost effective and efficient.
Mechanical polishing coupled with wet chemical etching is shown as a feasible alternative option to dry
etching. The effects of process variables on physical properties of CNT arrays have been studied and
quantified in order to demonstrate control over the process. Scanning Electron Microscopy has been used
to qualitatively understand the differences between CNT arrays fabricated using dry etching and the
alternative process. Cell culture has been demonstrated on the CNT arrays and the potential to use 3D
printing to fabricate a nanofluidic device is also demonstrated. The alternative process can save etching
time by 97% while maintaining a similar level of control over the process. This study therefore, opens the
path to quicker production of CNT arrays at low cost for biomedical use.
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1. Introduction
According to the American Medical Association, the cause of more than 4000 serious diseases can be
attributed to gene disorders [1]. These diseases include cancer, acquired immune deficiency syndrome
(AIDS), cystic fibrosis, Parkinson’s and Alzheimer’s diseases. The cause may be gene mutations or
missing genes caused due to external factors such as radiation, viruses or in many cases, mutations during
deoxyribonucleic acid (DNA) replication. Most of these diseases are known to be incurable in the true
sense of the word. Although there exist methodologies to slow down the spread of diseases like cancer
and Parkinson’s, they are far from perfect, often resulting in harmful side effects and severely limiting the
patient’s abilities and reducing quality of life.
In the 1980’s, multiple studies were carried out
on animal models to study the feasibility of
transferring healthy genes into cells which upon
expression in vivo would result in the
development of healthy cells. This method of
healing is known as gene therapy. It has in recent
times been explored as a cure for cancer [2, 3],
Figure 1.1: Mechanism of gene therapy

cystic fibrosis [4], HIV [5, 6] and color blindness

[7] with highly encouraging results. The crux of gene therapy is to transfect stem cells with DNA or other
proteins in vitro, depicted in Fig. 1.1. These cells, once genetically modified can repair, replace or inhibit
the action of a specific DNA strand. The altered cells are then capable of developing immunity against
attacking viruses causing the disease, express DNA which was earlier deficient to overcome a genetic
disability or grow into enhanced macrophages which can further fight the disease in question. It can be
concurred that the most important element of gene therapy is to develop a method for transfecting of cells
with the DNA or protein in question without inducing harmful side effects and ensuring cell viability.
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Transfection into cells for gene therapy conventionally has been carried out using viral vectors or lipids
[6, 8-12]. Viruses have the unique ability of expressing their genetics in the cells they infect. This ability
of viruses has been taken advantage of by modifying viruses to express a desirable genetic code rather
than a harmful one. However, side effects such as immunological attacks on viruses, homologous
recombination and cytopathic effects must be considered when using viruses for transfection [10]. Other
commonly methods of transfection being used include electroporation – the application of an electric field
to cells allowing charged particles to move into cell [13, 14]; particle bombardment – bombardment of
particles onto the cell membrane at high velocity with the intent of them breaking through the cell
membrane [15]; and the use of micro needles and wires to inject into individual cells [16].
Each of these methods has been successful in transfecting cells with appreciable efficiency yet they pose
multiple issues which are yet to be resolved:
•

Ensuring cell viability post transfection process

•

Controlling the amount of cargo delivered to cells

•

Cost effectiveness

•

Transfection into different cell types

•

Ensuring long expression times

The above issues, most notably, ensuring cell viability post transfection process has been one of the
biggest limiting factors for further expanding research in gene therapy and large-scale implementation of
this technology. A number of researchers have explicitly expressed the importance of safer, more viable
transfection technologies to accelerate research in gene therapy and for large scale applications [11, 12,
17].
“The message we have extracted from a history of anticipation and disappointment is that the
future success of gene therapy will be founded on a thorough understanding of vector biology and
pharmacology (Kay et al, 2003).” [10]
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“The success of gene therapy is largely dependent on the development of a vector or vehicle that can
selectively and efficiently deliver a gene to target cells with minimal toxicity (Li. et al, 2000)” [18]
“we are still far from the perfect gene carrier suitable for clinical use (Niidome et al, 2002).”[15]
In 2013, Golshadi et al [19]. were able to manufacture an ordered array of carbon nanotubes (CNTs) by
carrying out template based chemical vapor deposition (TB-CVD) of anodized aluminum oxide (AAO)
and applied it to nanofluidic transport applications. The CNT array thus developed consisted of highly
ordered, vertical carbon nanotubes, open from both ends and supported by an AAO template. This CNT
array showed encouraging results when utilized to transfect cells by culturing cells on the device [20],
shown in fig. 1.2. Compared to current state of the art methods such as particle bombardment,
electrochemical methods and micro-injections, CNT arrays are minimally intrusive, caused no damage to

Figure 1.2: Schematic of CNT array device for intracellular delivery
the cells and achieved higher transfection efficiency. This is a breakthrough invention for biologists and
genetic engineers working on drug delivery, gene therapy, cell therapy and studying the effects of novel
synthetic genetic material on cells. CNT arrays also present the advantage of being able to interface with
multiple cells in parallel, allowing for injections at a larger scale compared to individual injections.
CNT arrays offer the following advantages over current technologies:
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•

High transfection efficiency

•

Controlled volume of delivery

•

Cell viability

•

Ability to transfect multiple cells in vitro

•

Potential to transfect cells such as neural cells and stem cells

A limiting factor for CNT array technology is the current fabrication procedure for CNT arrays. Being
time consuming and requiring specialized processes is hindering large scale fabrication and exploration in
further areas of research which can exploit CNT arrays to their full potential. In order to explore large
scale manufacturing feasibility and bring down costs, it is important to study the fabrication methods
available to make these devices and suggest potential improvements.
Fabrication of the CNT array device currently involves the following steps, schematically depicted in fig.
1.3:

Figure 1.3: Stepwise fabrication of carbon nanotube array
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Annealing of template: The template used to manufacture the CNT device is an anodized aluminum oxide
membrane (AAO membrane) which is 13mm in diameter and 60µm in thickness. The membranes are
annealed prior to CVD to prevent distortion during the high temperature CVD process.
Template based chemical vapor deposition: The membranes after annealing are ready for CVD. During
CVD, the membranes are exposed to a continuous flow of ethylene in a sealed, high temperature furnace.
The CVD set up used is depicted in fig. 1.4. Breakdown of ethylene leads to the deposition of carbon on
the membrane surface and pores. The carbon deposited inside the pores of the membrane forms tubes.
Carbon is deposited in its amorphous form and is not graphitic.

Figure 1.4: Schematic showing chemical vapor deposition (CVD) set up

Oxygen plasma etching: Before aluminum oxide can be etched away to expose tips of nanotubes, the
layer of amorphous carbon deposited on the surface must be cleaned to expose aluminum oxide for
etching. Oxygen plasma is used to selectively remove only the carbon layer and prepare the device for
reactive ion etching.
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Reactive ion etching using boron trichloride (BCl3): Reactive ion etching (RIE) is a combined physical
and chemical etching method carried out in a weakly ionized plasma. BCl3 plasma is used to selectively
etch aluminum oxide in a controlled manner. Etching is carried out to achieve an exposed length of
~250nm of nanotubes.
The device has demonstrated impeccable transfection into cells with minimal damage [20], however,
there is scope for greater research such as studying the effects of variations in physical array dimensions
on transfection, the method by which interfacing of device and cell occurs, transfection into a variety of
cells and its application on tissue. These experiments require a large number of expendable CNT arrays.
Also, the CNT arrays need to be produced quicker and with greater ease to make them feasible for large
scale use in laboratories.
fig 1.5. Shows graphically the time consumed in each manufacturing process.

Figure 1.5: Breakdown of time required to fabricate CNT arrays
•

The annealing process: Annealing takes up approximately 10 hours to anneal 10 membranes

•

The CVD process: The CVD process requires another 10 hours to coat 7 membranes

•

Oxygen plasma etching of amorphous carbon layer is a 20-minute process
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•

Reactive ion etching using BCl3 is a 6 -12-hour long process which required specialized
equipment and trained personnel to operate this equipment. BCl3 is also a highly toxic gas
which is described as hazardous.

Currently the process to fabricate these membranes can take up to 4 days for a batch size of 7 membranes.
While the process can be scaled up using more sophisticated, large-scale equipment and parallel
processing of batches, it is hindered by multiple issues which cannot easily be addressed.
A dry etching process is also resource intensive. This hinders large scale economic production of these
arrays since setting up of such equipment is extremely costly which makes the commercialization of these
devices difficult.
CVD and RIE processes, unlike conventional manufacturing processes are dependent on physical
equipment variables such as size of chamber, voltage, power and position of substrate in the plasma
chamber. A set of manufacturing parameters resulting in desirable outcomes on a certain set of equipment
cannot be guaranteed to reproduce similar outcomes on a different set up. Equipment based variability is a
major obstacle in ensuring repeatable results and preventing manufacturing errors. This is also a major
obstacle in scaling up the current manufacturing system since a complete parametric study will be
required with any type of equipment before it can be set up.
This thesis explores alternative nano-fabrication processes to overcome the above-mentioned drawbacks
associated with the current process. Ease of scale-up, control over physical dimensions of CNTs and ease
of access were considered while exploring alternative fabrication processes. A combination of mechanical
polishing and wet chemical etching is presented as a feasible alternative with the potential to reduce
etching time from the range of 6-12 hours to 10-40 minutes. The process variables affecting CNT
properties have also been studied and quantified in detail followed by a qualitative assessment of device
quality using scanning electron microscopy.

17

2. Background

2.1 Gene Therapy
The method of gene therapy is gaining popularity in treating diseases which have a genetic background.
According to the American Medical Association, more than 4000 diseases have their root causes in
genetic mutations or alterations caused due to microbes [1], external factors such as radiation,
environment or errors during reproduction. Gene therapy in its most basic forms aims to rectify the
problem by delivering the missing or dysfunctional gene into a patient’s cells to allow for propagation of
healthy cells and genetics.
One of the most comprehensive definitions for gene therapy is given by the European Medical Agency:
[21]
“A gene therapy medicinal product is a biological medicinal product which fulfills the following two
characteristics: (a) it contains an active substance which contains or consists of a recombinant nucleic
acid used in or administered to human beings with a view to regulating, repairing, replacing, adding or
deleting a genetic sequence; (b) its therapeutic, prophylactic or diagnostic effect relates directly to the
recombinant nucleic acid sequence it contains, or to the product of genetic expression of this sequence.
Gene therapy medicinal products shall not include vaccines against infectious products.”
Gene therapy, as defined above, aims to deliver into cells the missing or deficient genes to enable
expression of proteins which can act therapeutically against the disease in question. The most common
mechanism employed in clinical trials around the world today is depicted in fig. 2.1 below: [22]
Step 1: Blood cells or stem cells are extracted from the patient and incubated. Stem cells can differentiate
into a variety of specialized cells and hence, they are preferred for gene therapy. Through injection of the
missing genetic material, stem cells can be made to differentiate into healthy cells with the ability to fight
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disease such as enhanced macrophages. In some cases, they are modified to prevent a certain microbe
from entering the cell, as in the case of gene therapy for the human immunodeficiency virus (HIV).

Figure 2.1: Process of gene therapy (A) using a viral vector (B) using non-viral vector

Step 2: The required cargo to be delivered is packaged inside a ‘vector’. The vector is a carrier with the
ability to permeate the cell membrane and deliver cargo without damaging either cell or cargo. The vector
should satisfy the following conditions:

1

•

Be able to permeate the cell membrane

•

Not induce any cytopathic effects in cells

•

Not induce homologous recombination 1

•

Be non-toxic

•

Should not initiate immunogenic response against itself

•

Be a safe carrier for cargo

•

Carry required amount of cargo

Exchange of nucleotides between similar DNA
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The most common vectors used for gene therapy have been viruses which were genetically modified from
their original form to be non-toxic and satisfy to an extent the conditions listed above.
Step 3: Cells collected from step 1 are infected with viruses modified in step 2 using techniques which
will be briefly discussed in the next section. The viruses express the modified DNA they carried as cargo
in the infected cell, leading to the creation of genetically modified cells. These cells upon division will
now express the effects of the infected gene.
Step 4: Injection of genetically modified cells back into the patient. The cells once injected into the
patient will now follow instructions coded in the cargo delivered to them. This will allow cells to
differentiate into specialized cells to fight diseases or produce proteins which can mitigate the effect of
disease.

2.1.1 Conventional Gene Transfection Technologies
It can be seen from the above section that designing an efficient vector is one of the most critical elements
of a gene therapy based healing process. In fact, the first trials of gene therapy were made possible only
after Roger and Pfuderer [23] showed proof of concept for genetic transfer into mammalian cells using
viruses. Ever since, viruses have been used as vectors for transduction in gene therapy clinical trials for a
number of diseases such as cancer [2, 3, 24], HIV [6] and others [4, 25, 26].
Viruses are microorganisms which are highly efficient in gaining access to cells and introducing viral
DNA into their host cells. With this method, viruses are able to hijack the host cell into creating more
copies of the virus. In the case of gene therapy, the ability of a virus to infect cells with its DNA is an
advantageous capability. However, the viral DNA leading to toxicity and replication should be deleted
and replaced by desirable cargo, depicted in fig. 2.2 before the virus can be allowed to infect the cell [27].
Sequences governing the functioning of the virus are left untouched but viral genes which lead to disease
and toxicity are deleted. The protein to be expressed is cloned into the viral backbone in place of deleted
genomes.
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The viral vector particles also require purification which is often carried out using density gradient
centrifugation. This step is often difficult to carry out and results in damage to the viral vectors,
decreasing the number of viruses which can infect cells. Column chromatographic methods are also
implemented and have overcome many drawbacks of centrifugation. [10]
Some of the viruses commonly used in gene therapy are as follows:
Lentiviral Vectors: Lentiviral vectors are derived from the HIV virus [27]. They have been used in gene
therapy for the correction of β-thalassemia and X-linked [25, 28] adrenoleukodystrophy [29]. They have

Figure 2.2: Modification of virus to create a viral vector

been used in earlier gene therapy trials owing to an ability to very well transcribe their ribonucleic acid
(RNA) into cDNA2 of host cells which makes them good gene carriers into target cells [11]. However,
lentiviruses and retroviruses still pose significant toxicity to the host cells. Lentiviral vectors were used in
a gene therapy trial which was published in April 2000 to treat severe combined immunodeficiency
(SCID)-XI disease. A leukemia like disorder in two of the patients was observed and led to much anxiety
in the field of gene therapy. The retrovirus genome had inserted itself near a cancer-causing protein in the
LIM domain3, activating its expression. [30]

2
3

Complementary DNA
Structural protein domain playing important role in organ development, oncogenesis and cytoskeletal organisation
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Adenovirus Vectors: Adenoviruses are different from lentiviruses in the sense that they do not integrate
into the genome of the cell [8], thus limiting the expression of their cargo to only limited number of cell
generations before transduction is required again. Adenoviral vectors have also been popularly used for
transfection in a number of clinical trials but have had their share of side effects. In 1999, 18 year old
Jesse Gelsinger was part of a clinical trial at the University of Pennsylvania [31] aimed at treating
ornithine transcarbylamase4 deficiency. This deficiency can cause an accumulation of ammonia in the
bloodstream leading to an ammonium buildup in the brain which is a fatal condition. Gelsinger developed
high fever within 4 hours after delivery of the viral vector and died 4 days later due to multi organ failure.
The vector had accumulated in the spleen, lymph nodes and bone marrow, resulting in intravascular
coagulation. Subsequent studies have shown that the adenovirus capsid protein can elicit an early
inflammatory cytokine cascade.
It is thus shown that viral vectors pose a number of dangers to patients who take part in gene therapy
such as eliciting immunological responses against viruses and destroying the vectors, inflammation,
limited transduction capabilities such as being able to transduce non-dividing cells only, oncological
effects, limited packaging capacity and others [32]. Viral vectors also present a challenge in terms of
storage, handling and scaling up of operations for commercial use. It is of importance to develop a
method of transfection which can achieve the same functionality without the above-mentioned side
effects.
To overcome these effects, the prospect of using non-viral vectors has caught up recently with a number
of non-viral vectors being developed for use such as lipids, polymers, nanoparticles combined with
physical means including injection, electroporation and gene gun [18]

4

Enzyme responsible for safe removal of nitrogen from amino acids and proteins
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Lipofection
Lipid refers to a class of special organic molecules, often fats, waxes, glycerides and oils that are soluble
in water. In biological reference, lipids are the main constituent of the cell membrane. They are also used
in the body as energy storage, signaling devices and to a lesser extent, for transportation.
Lipofection is a lipid mediated method of transfection wherein a lipid-DNA complex is formed, ready to
be accepted by the cell membrane. Often anionic molecules are bonded to positively charged lipids in
order to maintain a net positive charge on the complex. The cell membrane accepts this complex since the
membrane itself is a phosphobilipid layer with an overall negative charge. The anionic cell membrane and
cationic lipid-DNA complex are attracted to each other and form lipoplexes due to electrostatic
interactions. This leads the complex being taken up by the cell through endocytosis and the cargo
subsequently being released inside the cell.
This was first demonstrated in 1987 by Felgner et al [33] who used DOTMA for high efficiency gene
transfer into kidney cells and fibroblasts. They demonstrated that 100% of the DNA was encapsulated by
DOTMA in a 5:1 lipid to DNA ratio by weight. The transfection efficiency with varying concentrations of
DNA and lipid was observed to be as high as 100% but a significant downside mentioned is that the
DOTMA DNA complex would prove to be toxic beyond a certain concentration.
Lipofectamine, manufactured by Invitrogen is one of the commercially available lipofection agents
available and in widespread use. It is a cationic molecule which can form complexes with anionic nucleic
acids. Although high transfection efficiencies have been observed using lipofectamine, it still poses toxic
dangers to the cell. Madeira et al. [34] attempted transfection of green fluorescent protein (GFP) into
human mesenchymal stem cells (MSCs) and observed up to 35% efficiency but noticed decreasing cell
viability with an increased volume of lipid. Another drawback of using lipofection is that neutral cargo
such as quantum dots must be bonded to a charged protein before it can be used as cargo for lipofection.
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Microinjection
Microinjection can be viewed as a precursor to nanoscale devices. It refers to the physical injection of
material into the cell by physically penetrating the cell membrane using a micro-sized injection device
such as a needle or syringe. Fig. 2.3 shows microinjection into a single cell. The cargo to be delivered is
coated on the needle which subsequently penetrates the cell membrane and delivers cargo inside the cell.
Microinjection has widely been used in the creation of genetically modified animals such as pigs [35]
and expression of genes in mouse progeny by injection into mice eggs [36]. These are cases of small scale
transfection where a limited number of cells were injected with the required gene.
This method is victim to two major disadvantages:
a. Low cell viability due to invasiveness of the method: A microinjection device has dimensions in
the micrometer range which makes it invasive into the cell and reduces cell viability
b. Limited throughput: Transfection done on a cell by cell basis is prohibitively slow. For gene
therapy purposes, hundreds of thousands of cells need to be transfected. In such cases,
microinjection is limited by its low throughput.

Figure 2.3: Microneedle injection into single cell using a cargo covered
microneedle
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An interesting, alternative use of microneedles or microneedle arrays is in the field of transdermal drug
delivery. Drug delivery through hypodermic needles is often associated with pain and irritation, requiring
specialized personnel for injection. Oral drug delivery is subject to reduced efficacy due to first pass
metabolism in the body before the drug can reach its specified target. Microneedle arrays have been
shown to be a potential candidate for alternative drug delivery [16, 37-39]. They are associated with a
lack of pain, reduced dosage due to increased drug efficacy and easy delivery to intended site through
skin. These results are encouraging when it comes to applying carbon nanotube arrays for injection into
tissue.
Electroporation
Electroporation is a method of transfection in which an electric field is applied across the cell [14],
allowing it to take up charged DNA or other molecules which would under normal conditions not diffuse
across the cell membrane.
Under a short, high voltage electric field, phospholipid bilayers which are responsible for the integrity of
cell membranes open, depicted in Fig. 2.4, allowing charged molecules to flow into the cell. These pores
close immediately upon the removal of electric field. Electroporation has been found to work on a variety
of cells and is also applicable for transfection in vivo, it does present a number of disadvantages which
need to be overcome:
•

Collateral cell damage during electroporation is significantly higher.

•

Electroporation cannot permeate the cell nucleus.

•

The efficiency of electroporation depends on the electrical properties of cells being transfected.
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•

Limited control over the amount of material delivered into cells.

Figure 2.4: Schematic of electroporation. Adapted from [77]

Gene Gun (Particle Bombardment)
The gene gun utilizes high speed nanoparticles of heavy metals such as gold, platinum, titanium dioxide
or polymers coated with the cargo [40, 41]. These nanoparticles upon impact with the cell are able to
break through the cell membrane and thus deliver their cargo, shown in Fig. 2.5. The gene gun is effective
in the transfection of hard to transfect cells such as plant cells but with the advent of more controlled
methods, the use of particle bombardment has seen a decline. Some of the drawbacks of particle
bombardment are as follows:
•

Ability of the targets to resist damage due to high speed particles

•

Little control over amount delivered into cells

•

Potential toxicity of nanoparticle carriers

•

Damage to cells
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•

Low efficiency (20-30% expression)

Figure 2.5: Process of particle bombardment

The potential to overcome the above limitations set forth by viral and non-viral vectors can be explored
using injection devices which have been designed specifically to inject into cells with high efficiency
without damaging the cell membrane. Work in the field of nanotubes, nanowires and their arrays has shown
that these devices are capable of achieving transfection into cells. Researchers have different approaches
for transfection with these structures. A common approach is to use high aspect ratio nano-needles or pillars
with a height ranging from 2-6µm and a tip diameter in the tens of nanometers. Cargo is usually coated on
the surface of these pillars with the help of an amphiphilic coating [42, 43] and then delivered into the cell
when the needle or pillar penetrates the cell membrane by physically breaking through it. The cells might
penetrate the device under their own weight or in some cases, physical pressing or centrifugation [44] is
utilized to accelerate the process. Results from selected previous works are presented below.

3.1.2 Nano Structures for Transfection
In 2007, Kim et al [43]. prepared Si nanowire arrays with the intent of physically transferring material
into the cell by rupturing the cell membrane using nanowires. The nanowires were 90nm in diameter and
60m in length. Human Embryonic Kidney Cells (HEK293T) were grown on the clusters of nanowires
which seemed to penetrate the cell easily without any external force. Cargo was coated on the Si nanowire
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array and delivered into the cell through physical piercing of the cell membrane. This required
functionalizing the nanowires to bind cargo. The nanowire arrays were fabricated using gold
nanoparticles seeds planted on Si (111) wafers subject to CVD. The Si needle diameters were controlled
via etching in HF after oxidation. This was one of the earliest transfection attempts using Si nanowires.
Cell viability was observed at 78% with cells surviving a maximum of 3 days (Mouse embryonic stem
cells). Primary attempts at transfection were carried out on HEK293 cells with DNA electrostatically
attached to SiNWs. An efficiency of less than 1% was observed but this was attributed to the strong
bonding between SiNW and DNA.
In 2009, Shalek et al [42] were able to manufacture vertical SiNW arrays for transfection into cells with
the difference being mainly in the dimensions of nanowires. Although not explicitly reported, the SEM
micrographs convey wire lengths of 1m and diameter in the 50nm range. They used a similar
manufacturing method as Kim et. al. Transfection was attempted using multiple cell types such as HeLa,
human fibroblasts and rat hippocampal neurons. Regardless of the type of cells used, they claim to have
observed a 95% transfection efficiency in all cells within 1 hour. They also utilized surface
functionalization to bind their cargo to the nanowires and the mode of delivery was mechanical piercing
of cells.
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VanDersarl et al. in 2012 [45] developed silicon ‘nanostraws’ for direct fluidic access into cells. The
nanostraws were hollow, 100nm in diameter and 1m in height. Poly-carbonate membranes were used as
templates for aluminum oxide deposition. Alumina specific reactive ion etch followed by a polycarbonate specific etch were used to expose nanostraws. They used membrane impermeable dyes to
demonstrate transfection and observed 3-10% transfection rate of the cells pierced by the nanostraws.
Array devices fabricated by various researchers are shown in Fig. 2.6.

Figure 2.6: Devices fabricated by other researchers (A, B) Nanowires by Kim et al [43] (C, D)
Silicon nanostraws by VanDersarl et. al [45] (E, F) Silicon nanowire arrays by Shalek et al [42],
scale bar 1µm
The above are examples of using devices in the microscale for cell transfection. It is observed that even
though extremely high aspect ratio devices do facilitate transfection, the efficiency of transfection and cell
viability observed has been generally low (Table 1) and not feasible when compared to traditional
methods such as lipofection or electroporation. The fact that these methods rely on puncturing the cell
membrane to physically interface with it begs greater study on whether a tight seal is formed around the
cell – structure interface or contents of the cell are in danger of leaking out. Smaller structures or a lower
aspect ratio, such as the carbon nano syringe array developed in 2008 by Park et al [46] have been shown
to exhibit higher transfection efficiencies. The carbon nano syringe arrays were fabricated with a diameter
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of 50nm and heights of 80 and 120nm using TB-CVD process followed by ion milling and wet etching,
which is a method very similar to the one employed by Golshadi et al. However, nano syringe arrays
differ in the fact that they only have one open end, thus requiring preloaded cargo inside tubes before
cells can be seeded on them. They were able to achieve 85% cell viability compared to the control and
37% overall gene expression. Golshadi et al. [20] demonstrated transfection using carbon nanotube array
on HEK293 cells with propidium iodide (PI). They confirmed 98% cell viability using flow cytometry
and observed 99% transfection within viable cells. This study shows us that carbon nanotube arrays with
a lower aspect ratio are a more feasible method to transfect cells. Hence, in this study, we focus on the
low cost fabrication of a device similar to the one developed by Golshadi et al.
Table 1: Comparison between array devices developed for transfection

Device

Type

Cell Transfected

Cargo

Viabil

Efficiency

ity
Kim et al.

6µm tall wires,

HEK293

DNA-GFP

NIH3T3 Cells

pEGFP

CHO cells

Plasmid DNA

-

<1%

85%

30%

90nm tip
diameter
Park et al.

120nm tall, 50
nm diameter.
Carbon
Nanosyringe

McKnight et al.

7µm tall carbon
nanofibers,

-

<1 %

(pGreenLantern-1)

30nm tip
diameter
Golshadi et al.

CNT array

HEK293

PI

98%

99%

EYFP

84%

100%

205nm diameter
176nm high
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Irrespective of the results obtained, we can observe that most devices developed required forms of
reactive ion etching, silicon microfrabrication techniques or other methods which can hinder their largescale development either due to lack of equipment availability or prohibitive costs. We thus wish to
explore a low cost; high throughput manufacturing technique will make these devices available to
researchers in need of such technology en masse.
Another advantage of carbon nanotube based devices is the possibility of adding multifunctional
capabilities through functionalization to convert them into sensors while being able to transfect into cells.
Section 3.3.1 mentions the applications of carbon nanotubes for sensing through chemical
functionalization.

2.2. Carbon Nanotubes – Properties and Applications
Carbon nanotubes are a unique fullerene type allotrope carbon. They can be in the form of ordered, rolled
up sheets of graphene or have an amorphous crystal structure depending upon their manufacturing
technique. Carbon nanotubes, due to their varied atomic arrangements, exhibit mechanical, optical and
electronic properties which can vary across a large spectrum. This also makes them useful for a wide variety
of nanobiological applications such as tissue engineering, drug delivery, in vivo sensing applications, gene
therapy and cancer treatments.
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Atomic Structure of CNTs
Carbon nanotubes are classified as shown in Fig. 2.7:

Carbon Nanotube

Graphitic

SWNT

MWNT

Amorphous

DWNT

Figure 2.7: Classification of carbon nanotubes

Amorphous CNTs have no long-range crystal structure and are basically amorphous carbon in a tubular
shape. Graphitic CNTs are further classified as single walled nanotube (SWNT), multiwall nanotube
(MWNT), double wall nanotube (DWNT). They can be visualized as rolled up sheets of graphene. SWNTs
are a single tube while DWNT and MWNTs are visualized as concentric, multiple tubes. DWNTs are often
classified as a separate category from MWNTs since they can be obtained with high purity. MWNT samples
often have SWNTs present and vice versa. SWNTs have a diameter of 3-7nm while MWNTs can be up to
25nm in diameter. The lengths of CNTs have been observed in the order of microns. During template based
CVD, the dimensions of CNTs produced depend upon the template used.
The structure of graphitic CNTs can be described by the ‘Chiral Vector’ for CNTs made out of rolled
graphene sheets. In Fig. 2.8, the chiral vector is made of the components ma 1 and na 2 with a 1 lying across
the carbon atoms and a 2 in the direction of the reflection of a 1 over the ‘arm chair vector’ which divides
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all

hexagons

in

half.

The

wrapping angle is defined at the
angle between the chiral vector
and arm chair vector. If ɸ=0, the
tube is known as an armchair
tube, if ɸ=30, it is a zigzag type
and for 0<ɸ<30, it is a chiral tube.
The values of m and n describe the
chirality of the tubes and also its
diameter. The chirality can be
used to deduce the mechanical,
electrical and optical properties of
Figure 2.8: Chirality of graphitic carbon nanotube [78]

a nanotube. A single walled
nanotube will exhibit conductive properties if n-m is a multiple of 3 and otherwise semiconducting. Carbon
nanotubes have also been fabricated in an amorphous carbon form by multiple researchers. Carbon
nanotubes formed after CVD are usually in the amorphous form since graphitization of carbon requires
temperatures above 1200°C. Amorphous nanotubes differ from their graphitic counterparts in having lower
electrical and thermal conductivity. The physical properties of amorphous tubes cannot be controlled by
adjusting parameters such as chirality. However, for our application, amorphous nanotubes are easier to
manufacture due to the lower CVD temperature and time needed. Dimensions of amorphous carbon
nanotubes can be controlled by changing the template dimensions, leading to easy control of size over the
resulting tubes.
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2.2.1. In Composite Materials
Mechanical studies on CNTs have shown them to be the strongest materials known to mankind. They also
possess an extremely high young’s modulus. This makes CNTs especially attractive in structural
applications. Lau et al [47] have demonstrated the use of CNTs in epoxy composites. They observed that
despite their high strength and stiffness, CNTs did not offer satisfactory interfacial bonding at the CNTepoxy interface. This work was further supplemented by Kim et al. who used surface modifications to
improve interfacial bonding and showed the feasibility of using CNTs in epoxy composites. Nanobiological applications of carbon nanotubes can greatly benefit from the high strength of carbon
nanotubes in applications pertaining to cellular injections using CNT probes. Also, since cells can be of
varying mass and sizes, stronger structures minimized the risk of yielding or breakage of tubes inside
cells or within the extracellular matrix, eliminating chances of cytotoxicity.
CNTs can also be looked at as the most idealized and defect free form of carbon fiber, with mechanical
properties close to theoretically predicted values of properties for carbon fiber. Gojny et al. showed that
even an addition of 0.1 wt.% CNTs in epoxy to led to an increase in Young’s modulus from 3.29 to 3.50
GPa. [48]

3.2.2 In Electronics:
As consumer electronics continue to shrink with more functionality being added to smaller circuits, CNTs
are looked up to replace metallic wires which cannot be shrunk down to the nano-scale. From an
electronics point of view, nanotubes offer the following advantages:
·

Conventional metals and semiconductors have in their lattice structures multiple defects, holes
and dangling bonds. This leads to collisions and scattering of charge carriers which in turn
produces heat and reduces the maximum current density that can be carried by the conductors.
Carbon nanotubes possess near perfect structures with all chemical bonds satisfied, this implies
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that conduction is possible with lesser heat dissipation and at maximum current density of 109
A/cm2 compared to 104 A/cm2 for metallic conductors [49]
·

CNTs have high mechanical and thermal stability. This is due to the strong covalent bonding
between carbon atoms.

·

They can be made to behave as both metals and semiconductors depending upon their atomic
arrangement. This property of CNTs can be utilized to make complete electronic circuits with
both transistors and interconnects using only nanotubes.

High conductivity and small size makes carbon nanotubes worthy of use in cellular electrochemistry,
further enhancing their use as sensors and adding multifunctional capabilities to them.
Nanoscale field effect transistors and gates have been developed using SWCNTs. It has been shown that
CNTFETs even at a nascent stage of development are competitive compared to the current state of the art
technology available. IBM expects nano electronics to be realized within this decade as an alternative to
silicon microstructures. CNT are also being looked into for use in Li-ion batteries and fuel cells [50-52].
They have a high surface area to volume ratio, offer more intercalation sites in the form of interstitial
spaces and tube cavities. CNTs also have an affinity for hydrogen adsorption which makes them a
potential candidate for use in fuel cells and replace traditional platinum catalysts.

2.3 Carbon Nanotubes in Nano-Biotechnology applications
Unique and flexible mechanical, chemical, optical and fluid transport properties have found CNTs a
prominent spot in biomedical research.
The use of carbon nanotubes in biomedical applications includes using them as drug carriers [53, 54], for
transfection of DNA and proteins into cells [46], miniature biosensors with high selectivity and
sensitivity, targeted enzyme delivery, cell tracking and labelling, building of tissue matrices and as
imaging contrast agents. [49, 55, 56]
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2.3.1 Bio sensing
The nano-dimensions of CNTs make them suitable for interacting with individual cells. The possibility of
being able to monitor cell behavior, analyzing cell chemistry, ion transport, enzyme behavior and
secretions will be advantageous in comprehending many mysteries of drug behavior, physiological
responses at the larger scale and identifying disorders or unnatural behavior with greater accuracy.
Wang et al [57] have been at the forefront of exploring the use of CNTs as biosensors. They have shown
the applications of CNT/Teflon composite electrodes in detecting hydrogen peroxide and NADH.
Experiments also showed favorable response of the electrolyte over the complete potential range. The
CNT/Teflon electrode also responds very rapidly to changes in the level of hydrogen peroxide and NADH
and low noise levels. Wang et al also developed the first sensor with a CNT based electrode for
amperometric and voltammetric determination of insulin. They observed increased electron transfer
kinetics using CNTs.
In another study, Li et al [58]. were able to fabricate a CNT array embedded in SiO2 for ultrasensitive
DNA detection and were able to detect lower than a few attamoles of oligonucleotide targets. These
applications using carbon nanotubes provide encouraging results to utilize CNT arrays as multifunctional
devices for sensing, while at the same time behaving as drug delivery or transfection vectors.

2.3.2 Cell tracking, labelling
With the advent of artificial tissue constructs, it becomes important to be able to analyze the progress of
tissue growth in-vivo and visualize cell migration, cell multiplication. This needs to be carried out with
minimal intrusion to prevent external factors from influencing results. Conventional methods such as flow
cytometry or fluorescence microscopy are either complex and time intensive methods [59]. CNTs can
provide an alternative to these methods. Cherukuri et al [60] demonstrated the use of SWCNTs in optical
labelling. Excitation of SWCNTs dispersed in a pluorinc surfactant incubated with mouse peritoneal
macrophage-like cells resulted in a structured fluorescence spectrum. In vivo optical imaging is often
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hampered due to tissues that absorb light, narrow optical absorption and broad emissions. CNTs possess
optical transitions in the near infrared range which allows for greater penetration owing to lesser
absorption.
Nanotubes were also observed to have remained in cells after repeated cell divisions. This observation
encourages the application of CNTs in studying cell divisions and stem cell differentiation.

2.3.3 Imaging Contrast Agents and Radiotracers
Carbon nanotubes being composed purely of carbon provide poor contrast in MRI. This is overcome by
taking advantage of their ability to be functionalized. Heavy atoms such as gadolinium can be attached to
the surface of the tubes or caged inside them. The ‘Gadonanotubes’ thus produced displayed proton
relaxivities 40 times above Gd[(DTPA)(H2o)]-2 which is a standard clinical contrast agent.
Singh et al. [61] were able to demonstrate the in vivo biocompatibility of CNTs by functionalizing them
with radiotracers and studying their movement through the bloodstream. Indium (111In) was covalently
bound to SWNTs and administered to mice. The CNTs did not show a tendency to accumulate in a certain
organ and were cleared from the blood via renal excretion. They could also be visually observed in urine.
No mortality or toxic side effects were noted. This showed that CNTs can be used in vivo without
eliciting harmful side effects in the bloodstream and are excreted.

2.3.4 Tissue Engineering
Regenerative medicine is a method of healing that involves rebuilding damaged organs and body parts
using stem cells or genetic modifications. Cells when grouped together create around themselves their
own supporting structure called the extra cellular matrix or tissue scaffold which acts as a medium for
signaling molecules between cells. Through proper understanding of the requirements of cells and tissues,
there exists scope to modify or rebuild damaged tissues. [55, 62, 63]
CNTs have simplified methods to track cells, understand development of the tissue and study its viability.
Optical labelling of cells carried out using functionalized CNTs which easily permeate the cell membrane
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has the potential to track cells without using expensive, complex methods such as flow cytometry or
intravital microscopy. CNTs do not require specialized equipment or extraction of cells from the body to
detect cells but can be used in vivo. The chemical functionalization of CNTs can be carried out using
chemical methods only which greatly simplifies the process. CNTs with functional groups attached to
them can be detected by Raman spectroscopy [53]. When inside a tissue matrix, the chemical changes in
functional groups can be used to study microenvironments around the cell.
Implantable biosensors which can relay information in real time about vital tissue parameters such as pH
and glucose levels are also being explored [57, 64]. With a high surface area to volume ratio, the active
area available for analysis is large, which allows for higher sensitivity. Since CNT array devices can
interface with a number of cells in parallel, with the proper functionalization, they have the potential to
monitor a large number of cells in vivo and provide substantial amounts of data regarding cell behavior.
Another area of interest is the use of CNTs as structural support for tissue matrix [55, 63, 65]. The matrix
is a critical component of tissues and greatly affects its development. Conventional matrix materials are
usually synthetic polymers such as PLA, which lack the required mechanical strength. CNTs dispersed in
chitosan, a biopolymer, showed improved mechanical properties.
Gene Transfection
Carbon nanotube arrays have been used to achieve transfection into cells of different kinds. Park et al.
demonstrated transfection into fibroblast cells with up to 35% efficiency. Golshadi et al. demonstrated
transfection into HEK293 and were able to achieve 99% transfection in live cells. Carbon nanotube arrays
have also demonstrated the ability to transfect dye, DNA and quantum dots into cells, proving that they
can be used in a versatile manner.

2.4 Fabrication
The success of carbon nanotube devices is in part contingent upon their ease of fabrication and
accessibility. It was observed earlier that most array devices are manufactured using techniques which
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cannot easily be adapted to commercial scale fabrication with reasonable costs. In order to develop a
more feasible nanofabrication method, it becomes important to look at viable alternative techniques used
in micro-nano fabrication. Given the variety of applications requiring the use of CNTs, researchers have
formulated novel methods to fabricate them and control their physical dimensions. Some of the most
prominent ones are mentioned below.

2.4.1 Chemical vapor deposition
Chemical vapor deposition is a method of applying thin film coatings to materials and also to produce
high purity bulk materials.
It requires flowing a precursor gas over the heated object to be coated. High temperatures are maintained
by keeping the target item in a furnace. As the precursor gas flows over the target material, chemical
reactions occurring over it result in the deposition of a thin film on the surface. CVD provides multiple
advantages over other deposition processes such sputtering or physical vapor deposition.
Because precursor gases used in the processes can be obtained in very high purities, the deposited
material is devoid of contaminations, making CVD one of the most reliable methods to obtain a pure film.
The gaseous nature of active material means that all crevices, pores and open surfaces are deposited with
an even and continuous layer of film without breaks or large variations in thickness. It is also one of the
few methods which can deposit material films with nanoscale precision.
Apart from obtaining controlled and pure film depositions, CVD equipment and set ups are easier to use
and operate. Unlike sputtering, there is no line of sight requirement for CVD, as long as the precursor can
access the object to be coated. Regular CVD works without the requirement of plasma, ions or lasers but
these methods are often employed for specialized applications to improve yield or reduce time for CVD.
Depending upon the application, substrate requirement, material to be deposited, cost, precursors and
deposition requirement, different kinds of CVD reactors are available.
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1. Hot wall Reactor: These represent the more common and less complex CVD systems. They essentially
consist of a chamber containing the target substrate, with the chamber surrounded by a heat source. Walls
of the chamber are not cooled but heated by the heat source, thus the name ‘Hot Wall Reactor’. The
chamber can be of different sizes depending upon the number of parts to be held, with shelves or might be
as simple as a ceramic tube. Temperatures in these reactors are usually very high, limiting factor being the
materials used in the process or construction of reactor. Their advantages include being able to maintain
uniform temperatures resulting in even film thicknesses. On the downside, due to a heated chamber walls,
some deposition occurs on the walls of the chamber and gas inlets or exhausts, requiring frequent
cleaning. This may also lead to higher energy and precursor requirements. The CVD process used by
Golshadi et al. utilizes a hot wall reactor due to ease of use, even thickness of deposited film and
availability.
2. Cold wall reactor: These are another major category of CVD reactors. In this type, the chamber walls are
cooled by running coolant through them and only the substrate holder is allowed to heat up. The holder
may be heated using resistance heaters, induction or lamp heated. They are often used in high pressure
applications with more reactive precursors. Although they present the advantages of reduced deposition
on walls and lower thermal loads on substrate due to faster heat up and cool down times and consequently
lower energy consumption, they do present more complicated disadvantages which requires careful
process monitoring.
·

Non-uniform temperature distribution on the substrate, leading to non-uniform film thicknesses

·

Thermal stresses in case of quick heating and cooling

·

Smaller batch sizes compared to hot wall reactors

The use of TB CVD to grow nanotubes was first shown by Che et al in 1997 [66]. They showed that
CNTs could be grown inside AAO membranes and develop into highly ordered arrays. Precursors used in
the process were ethylene and pyrene. They also demonstrated the use of catalysts such as Ni, Fe and Co
upon the CVD process and resulting nanotubes.
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The compatibility of the nanotubes thus produced was not tested on biological systems since their primary
focus was on applying them to the anode of a Li-ion battery. They observed that carbon nanotubes inside
formed using ethylene as a precursor on Ni catalyzed AAO membranes were ordered and formed without
any macroscopic defects. It is also observed that further exposure to higher temperatures after CVD
converts the atomic structure of amorphous CNTs to ordered graphite.
Fe and Co were also explored as catalysts with ethylene as a precursor as 580°C for 30 minutes. In the Co
catalyzed membranes, CNT structures were formed but were not ordered or symmetric and fused
together. Fe catalyzed membranes did not show any sign of CNTs in them.
This study provides important insights for increasing the rate of CVD and possibly shortening fabrication
times. The observation that CNTs thus formed were conductive motivated the idea of applying them as
sensors.
Xu et al. [67] also demonstrate the growth of carbon nanotubes on AAO membranes while using cobalt as
a catalyst. They different from the devices manufactured by Che et al. since their CNTs grew out of the
membranes onto its surface. They go a step ahead to show how CNTs produced can be modified to
eliminate the effects of the catalyst on their applications by using ultrasonification to chop off the excess
CNT lengths from above the membrane. The AAO membranes utilized by them had an average pore
diameter of 60 nm and interpore spacing of 100nm. Co was deposited using electrodeposition and CNTs
grown using CVD with ethylene as a precursor at 650°C. Etching of AAO membrane was carried out
using an aqueous mixture solution of CuCl2 and HCl
TB-CVD is thus a well-established method for fabrication of nanotubes with different sizes and for a
variety of applications. The use of a hot wall reactor is selected for this study due to availability, uniform
film deposition thickness and ease of use.
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2.4.2 Etching technologies
Wet Etching
Alumina is an amphoteric oxide which can react well with both acids and bases. It has been established in
a number of studies that AAO can be fully dissolved using dilute NaOH, H3PO4 and HF. Researchers
have commonly used NaOH to release CNTs formed using TB CVD to release CNTs from the template
[68-70].
The following reactions take place when AAO reacts with an acid or base:
2OH- + Al2O3

2AlO2- + H2O

6H+ + Al2O3

2Al 3+ + 3H2O

There have been multiple studies carried out on wet etching of AAO membranes [68, 70-73]. The most
common etchants include NaOH, H3PO4, Hu. et al [70] have investigated the etching of AAO with H3PO4
and NaOH and reported linear mass dissolution rates for both. NaOH is also reported to be a stronger
etchant whereas the slower etch rate of H3PO4 makes it more suitable for exposing nanotubes due to better
control over exposed lengths. Golshadi et al. also carried out studies using wet etching with varied
concentrations and reported similar trends as Hu et al. They also observed a decrease in etch rate with
temperature. Lee et al. [74] who used AAO as a template to create gold tipped nano arrays also utilized
wet etching to eliminate the AAO template. They utilized a mixture of H3PO4 (6wt%) and Cr2O3
(1.8%wt) at 60°C for 1 day.

Dry Etching
Dry etching is commonly used in microfabrication to selectively remove material. In template based
manufacturing of array devices, dry etching has been used to selectively etch the template and expose
carbon nanotubes from template [20, 75]. Dry etching can be both reactive and non-reactive. Material
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removal achieved by exposing material to highly energized plasma. Plasma of reactive gases such as
boron trichloride, oxygen and fluorocarbons might be used to achieve a combined reactive and physical
etching mechanism, known as reactive ion etching (RIE). In other cases, non-reactive, heavy gases such
as argon or gallium are used to achieve a purely physical etching, called sputtering or ion milling.
Mechanism of dry etching
A dry etching set up typically looks like the one shown in Fig. 2.9. The plasma chamber is a sealed,
vacuum chamber with electrodes on the top and bottom. The lower electrode is where a sample to be
etched is placed. It is connected to an RF power supply and a blocking capacitor. When the process is
started, a vacuum pump evacuates the chamber down to low pressures (~5 MPa) and allows the required
etching gas to flow into the chamber. An alternating electric field is set up inside the chamber using the
RF supply. The most commonly used frequency for the electric field is 13.56MHz. At this time, electrons
being lighter, move with the electric field. During this rapid movement, they strike other atoms with high
energy which is usually higher than the ionization energy leading to either excitement of electrons in the
atoms or ejection of electrons, which leads to formation of more ions. As the population of electron
grows, cascade reactions take place which results in the formation of more and more ions. The plasma
formed in a reactive ion etching chamber is a weakly ionized plasma, also known as a glow discharge
plasma. An important characteristic of the glow discharge plasma is lack of thermal equilibrium between
electrons and ions. The temperature of electrons is related to their Kinetic energy through the relation:
[76]
3

½𝑚𝑒 𝑣𝑒 = 2 𝑘𝑇𝑒
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Where k is the Boltzmann’s constant. Thus 𝑇𝑒 >> 𝑇𝑔 , and the gas remains at approximately room
temperature. Because glow discharge plasma is a weak plasma, the number of electrons is lesser than the
number of ions, keeping the chamber at room temperature. The lower electrode upon which sample is
placed experiences a negative DC bias due to the presence of a capacitor. This leads to repulsion of

Figure 2.9: Mechanism of dry etching

electrons from the region near the lower electrode. Since no electron-ion interactions take place here, this
area is referred to as the dark region. As positive ions approach this region, they are accelerated due to the
local negative potential created at the lower electrode. These ions gain energy and are responsible for the
directional etching profiles obtained through dry etching. In our case, this process is able to uniformly
etch away the AAO membrane, leaving behind a smooth surface with no debris.
Ion Milling
Ion milling is a non-reactive method of dry etching and can be used to etch away the template in template
based fabrication techniques. It is not material specific, since the mechanism of dry etching is purely
physical. Unlike focused ion beam (FIB) milling or electron beam milling, ion milling is used for material
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removal over larger surface areas without specific targeting. Ion milling is a form of dry etching
characterized by the use of inert gases for etching. Most dry etching processes are some form of reactive
ion etching processes which involve chemical and well as physical interaction between ions and sample
material. The chemical reactions aid in etching, thereby accelerating the etch rate. However, the gases
used in reactive ion etching such as boron trichloride and carbon tetrafluoride are toxic and hazardous.
These gases require special handling considerations while at the same time etch much slower compared to
wet etchants such as NaOH or phosphoric acid.
Ion milling relies purely on the physical interaction between ions and the sample for material removal. In
its simplest form, it can be thought of as a method of ‘sandblasting using ions’. Energy transferred from
ions to atoms of the surface of the material allows atoms at the surface to gain enough energy to break
away from the crystal structure, resulting in material ablation. A lower pressure allows more ions to
impact the surface since the mean free path is inversely proportional to the ambient pressure. This also
decreases scattering of ions thus leading to a more directional etching profile, making ion milling
applicable to a variety of materials without much variation in etch rate. Milling using argon is inexpensive
and simple to carry out.
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2.4.3 The AAO template

A

B

Figure 2.10: Schematic representation of a cross section view for the Whatman Anodisc AAO membrane
(A) Magnified cross section view of template with dimensions. Dotted line indicates end of lattice layer (B)
fabrication process with lattice shown
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Fig. 2.10 is a schematic showing the cross section view of AAO membranes used as templates. These
membranes consist of ordered pores which run the entire thickness of the membrane and open at both
ends. Pore diameter at the top is close to 200nm and 250nm at the bottom surface. The top is also
characterized by presence of a mesh like AAO layer we call ‘lattice structure’. This lattice structure
hinders direct access to the pores and is non-functional for our use. During etching, considerable time is
spent in removing this lattice layer since ordered carbon nanotubes are not found in this region. The
required length of nanotube exposure is only ~200nm but time spent in clearing away this layer slows the
fabrication process. Removal of this layer prior to manufacturing is desirable because not only will it
reduce etching but potentially improve the quality of the array fabricated using wet etching. The use of
ion milling, wet etching and mechanical polishing are prospective methods of removing the lattice.
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3. Selection of Alternative Nanofabrication Process
In order to reduce fabrication time and increase yield, it became important to study and evaluate a number
of fabrication processes which could replace the current process. This chapter discusses the process of
selecting a feasible alternative nanomanufacturing method. Fig. 3.1 below shows the alternative processes
that were proposed to replace current methods.

Figure 3.1: Alternative proposed fabrication processes

Figure 3.2: SEM micrograph of array after etching with 1M NaOH for 6 minutes. Tubes
can be seen embedded inside pores (circled). (A) Normal view (B) 35̊ tilt view. Scale bar
500nm
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Figure 3.3: SEM micrograph of array after etching with 1M NaOH for 20 minutes.
Tubes can be seen coalesced together. (A) 35o tilt view (B) Normal view. Scale
bar (A) 500nm (B) 1µm

3.1 Wet Etching
Reactive ion etching, being the most expensive and time-consuming process, was of highest priority in
elimination. The wet etching of Aluminum oxide can be carried out by using easily obtainable compounds
such as sodium hydroxide and phosphoric acid. These compounds also present the advantage of easy
disposal and relatively safe handling. This makes wet etching a promising alternative to reactive ion
etching. Initial trials were carried out for the above process using O2 plasma followed by etching in 1M
NaOH.

Figure. 3.4: Schematic showing the progression of wet etching
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It was observed that despite the rapid speed of etching, its isotropic nature leads to a condition referred to
as pore widening. In Fig 3.2, we observe that after 6 minutes of etching the CNT array, part of the lattice
layer remains, covering the tubes. Tubes can be seen within the pores but they have not been exposed. At
20 minutes of etching, tubes are very clearly exposed however, the template has been excessively etched
and the thinner sections of AAO separating the pores have also been dissolved in the NaOH. This is
illustrated in Fig. 3.3 above. The lack of support resulted in CNTs collapsing upon one another and
forming a coalesced clump instead of an ordered array, depicted in Fig. 3.4. Another observation critical
to our application was the formation of towers on the surface which implied that etching was not evenly
carried out.
Based upon the above results, the following conclusions were drawn
1. In a short timeframe, wet etching is sufficient to expose a limited number of tubes. But, the lattice
structure will remain dominant with random peaks across the surface. With extended duration of
etching, pore widening becomes the dominant feature, this leads to a loss of support for the
nanotubes and eventual clumping together, most likely due to the surface tension of etchant.
2. If the lattice layer can be removed prior to etching the CNT arrays or prior to beginning the
fabrication process, wet etching can potentially expose the required length of CNTs in a short
amount of time without pore widening.
From the above conclusions, it could be inferred that a method to eliminate the lattice layer would be
beneficial prior to wet etching. Thus, a number of attempts were made to eliminate the lattice layer.
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Figure 3.5: Removing lattice layer before etching

Figure 3.6: SEM micrograph of bare AAO membrane after wet etching for 7 minutes in 1M
NaOH (A) top down view, arrows showing pores under partially etched lattice (B) 35 tilt view
showing pillars. Scale bar 1µm
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Figure 3.5 depicts the fabrication process proposed, involving the removal of lattice layer. The lattice
layer could be removed after the CVD process or prior to it. The first attempt was carried out using NaOH
to etch away the lattice from a bare AAO membrane. The images in Fig. 3.6 show that compared to an
unetched membrane, there is a significant reduction in the lattice, however, the presence of pillars is
observed. Since a smooth surface is required for the exposure of coplanar CNTs, alternative methods
were considered.

3.2 Ion Milling
A potential method to eliminate the lattice layer was to utilize ion milling. Initial studies carried out using
ion milling have provided proof of concept and encouraging results for removing the lattice layer. As
mentioned in Sec 2.4.2, the process of dry etching for AAO is not well documented. A method of wet
etching (referred to as the drop method) followed by dry etching was studied to observe the prospects of
using a hybrid method. This involved placing a small amount of etchant (in this case 1M NaOH) upon the
membrane to form a drop as shown in Fig. 3.7. It was done so to minimize etching from the bulk of the
template by reducing the rate of replenishment for available etchant in the pores. This sample was later
exposed to ion milling.
SAMCO RIE 1C, benchtop
reactive ion etching machine
Template
Pores

was used to carry out all ion
milling procedures. Ion milling
with multiple conditions was

Figure 3.7: Utilization of minimal etchant or ‘drop method’. This is

attempted, mentioned in Table 2

tried to reduce dissolution from bulk of membrane

below:
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Temperature

Power

Flow Rate

Pressure

Case 1

25ᵒC

100 W

45 SCCM

31.45 Pa

Case 2

25ᵒC

200 W

10 SCCM

12.97 Pa

Case 3

25ᵒC

200 W

74.21 SCCM

54 Pa

Table 2: Process parameters for Ion Milling experiments

3.2.1 Case 1:
Temperature - 25ᵒC, Power- 100 W, flow rate- 45 SCCM, Pressure- 31.45 Pa
Samples were of both types; bare AAO
membranes and carbon coated
membranes, with amorphous carbon layer
present. The experiment was run for 10,
20 and 30 minutes.
Its observed that Ion milling at this
specification did not have much effect on
the membranes. Both samples, even after
Figure 3.8: SEM micrograph, normal view of carbon coated
membrane after 30-minute ion milling. No material removal
is observed.

30 minutes did not show significant signs
of material removal as seen in Fig. 3.8.

3.2.2 Case 2
Temperature – 25 C, Power- 200W, Flow rate- 10 SCCM, Pressure – 12.97 Pa
Using a lower pressure as recommended by SAMCO Engineers, etching was carried out again on similar
samples, both bare and carbon coated. Using a lower pressure increases the mean free path of gases. This
increases the probability of an ion striking the surface of the membrane. Also since inter-ionic collisions
are reduced, it is expected that ions with higher energy will strike the surface, leading to more material
removal. Etching under these conditions was carried out for 30 minutes, 60 minutes and 90 minutes. The
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SEM micrographs in Fig. 3.9 show that considerable material removal took place at the end of 90
minutes. In contrast, carbon coated membranes showed very little material removal as compared to bare
membranes, promoting the idea that removal of lattice layer prior to CVD might be easier.

Figure 3.9: SEM micrograph of plain AAO membrane after 1.5-hour ion milling. Pits and
craters can be seen, indicating material removal. (A) Normal View (B) 35° Tilt view showing
non-uniform etching. Scale bar 1µm

3.2.3 Case 3
Wet etched 7 minutes, 1M NaOH
Temperature – 25 C, Power- 200W, Flow rate- 74.21 SCCM, Pressure – 54 Pa
Membranes were first etched for 7 minutes using 1M NaOH. The method of etching was different
because a small volume of etchant utilised to minimize etching from inside open pores as shown in Fig.
3.7. This time, a higher pressure was utilised i.e. a higher gas flow rate to have a larger number of free
radicals in the plasma and thus more etching. Ion milling was carried out for 1 hour with the abovementioned parameters in 4 runs of 15 minutes. This was done to prevent the machine from overheating. It
was observed that there was significant exposure of the pores. The pores also appear to be clogged by
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debris, which can be seen in Fig. 3.10. However, this is an encouraging result since removal of lattice
layer is explicit and ordered pores can be identified.
In the above processes, it was observed that ion milling had the potential to remove the lattice later but
left the membrane with an uneven surface morphology. Ion milling is also not a physical process but a

Figure 3.10: SEM Micrographs of bare AAO membranes after 7 minutes wet etching using
‘drop method’ and subsequent ion milling for 1 hour. (A) scale bar 5µm (B) scale bar 2µm.
Material removal is comparatively uniform and pores are beginning to show (marked with
arrows)
plasma based process which can potentially vary on different equipment. It is also important to note that
carrying out CVD on clogged membranes with an uneven morphology would not result in coplanar
CNTs. To overcome these disadvantages, other methods were considered.

3.3 Mechanical Polishing
The most desirable fabrication process is one that poses least variability, easy scale up opportunities and
preferably can be carried out without the use of cleanroom facilities. Since the lattice layer is about 1µm
deep from the top of the surface, polishing was considered as a potential option. Mechanical polishing
poses the advantage that it is easy to scale up, is free of cleanroom requirements and is not subject to
variations due to plasma or other dynamic systems.
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Figure 3.11: Polishing set up schematic

3.3.1 Case 1: Polishing bare AAO membranes:
Bare AAO membranes were polished on a Struers TegraPol using 1µm DiaPro diamond suspension. The
polishing set up is shown in Fig. 3.11. Bare membranes were subjected to 12 minutes of polishing at
150RPM.
In Fig 3.12 and 3.13 it is seen that the lattice layer seems to have been eliminated and pores are visible.
The pores are clogged with debris from polishing. Further trials were carried out using polishing followed

Figure 3.12: top down view micrographs of polished membranes, 15N, 150RPM (A) 3 minutes
(B) 6 minutes (C) 9 minutes (D) 12 minutes, scale bar: 1um (A, B), 500nm (C, D)

Figure 3.13: Top down micrographs of polished membranes with increasing force (A) 20N
(B) 25N (C) 30N, for 5 minutes. Dark spots are covered pores. Scale bar 1um
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Figure 3.14: SEM micrographs showing polished bare membranes (A) 12 minutes, 15N (B)
18 minutes, 30N.Both were followed by 3 min etching with 1M NaOH Scale 2µm
by wet etching. After 3 minutes of polishing at 15N, there is significant reduction in the lattice, shown in
Fig. 3.14 (A) By increasing force to 30N and stepping up the time to 18 minutes, there is a very clear
elimination of lattice from the surface of membranes seen in Fig. 3.14 (B). This brings us to a definite
conclusion that polishing is a very promising process for this task.
These membranes were then annealed in preparation for CVD. Polished membranes after annealing
resulted in curling of the membranes which rendered them imperfect for cell culture studies. Since
polishing is a non-selective process, it can be carried out after the CVD step thereby leading to the

Figure 3.15: Top down micrographs of CNT arrays. Polished for 20 minutes at 30N, etched
with 1M NaOH. (A) 3 mins (B) 5 mins. Scale 2um
reduction in steps, increasing yield by reducing damage to membranes during the polishing process and
preventing polished and annealed membranes from curling during the CVD process.
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3.3.2 Case 2: Polishing carbon coated devices
In Fig. 3.15 polished and etched CNT arrays are shown. The crusty appearance of the CNT arrays was
found to be due to excessive sputter coating in preparation for electron imaging. Some amount of
clogging can be observed within the CNTs. The cause and solution to clogging will be further discussed
in the following chapter.
From the above images, following conclusions can be drawn:
1. Polishing is a simple and effective technique to eliminate the lattice layer.
2. There exists control over the polishing process through mutually independent variables such as
time and force
3. Clean room facilities are not required for polishing
4. Scaling up of polishing will be a much simpler operation than scaling up of a dry etching process
5. Polishing poses a higher risk of damaging membranes
Based upon the above points, it was decided that polishing, combined with wet etching is the most
feasible fabrication technique for mass production of CNT arrays. Hence, further studies were dedicated
to the optimization of this process and understanding the variables that affect it.
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Chapter 4: Effects of Synthesis Parameters on Carbon
Nanotubes
After analyzing the observations made during experiments mentioned in chapter 4, it was clear that
mechanical polishing was a viable alternative solution for the fabrication of CNT arrays. To effectively
implement a fabrication process, it becomes important to comprehend in totality the behavior of the
process under varying conditions. It was also important to understand the extent to which this process
could be controlled in order to yield CNT array devices of required dimensions such as tube height and
diameter. In this chapter, effects of the different process parameters with respect to physical properties of
CNTs are discussed. During the polishing – wet etching process, the following parameters can be
controlled:
Polishing: Force, time, size of polishing particles
Wet etching: Etchant, concentration of etchant, time

4.1 Effect of Polishing Parameters
Mechanical polishing was shown to potentially eliminate the lattice layer and overcome the issues
associated with plasma based processes. The image in Fig. 5.1 depicts the polishing set up:
1. Mounting of carbon deposited membranes on aluminum stubs: Aluminum stubs were cleaned
thoroughly with acetone to make sure they were free of impurities and leftover wax from earlier
processes. The stubs were then heated to 150 – 160°C on a hot plate, this is twice the flow point
(78°C) of the 7071 Blanchard wax used. When stubs are warmed up, a stick of 7071 Blanchard
holding wax (acquired from the J.H Young Co.) is used to apply a thin layer of wax on their
surface. The wax so applied should be even thickness and have no air bubbles. The device is
placed on the wax and let allowed to settle down for 45s – 1 minute, until it is seen that the entire
surface of the devices contacts wax (this is confirmed by observing the wetting of the devices by
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the wax which can be visibly observed). Any section of the membrane not in contact with that
wax poses an increased risk of the device cracking during polishing. Care should be taken at this
point to make sure that the wax film is even, this is imperative to prevent high and low spots on
the mounted device and ensure even polishing. The stub is then allowed to cool down to room
temperature. Excess wax can be cleaned by rubbing gently on a Kim wipe wetted with acetone.
2. Polishing: The stub is placed in the holder of the Struers TegraPol and polished with set force for
a given time. The MD-Floc polishing pad should be lubricated with 4-5 drops of green water
based lubricant for every 5 minutes of polishing. After polishing, stub is placed under running
water to clean off polishing slurry and allowed to dry under an air dryer.
3. Dismounting of polished device from stub: The stub with the device on it is heated to 140°C on a
hot plate. When the stub is warmed up, acetone is poured using a dropper on the stubs to help
dissolve wax and free the device. Using constant addition of acetone via a dropper, the device is
picked up using tweezers and rapidly transferred to a vessel containing 99% acetone. This is
carried out rapidly with great care to prevent the solidification of wax on the device which can
result in the contraction of the wax and excess strain on the device resulting in damage or curling.
The device is left in the acetone bath for 5 minutes to dissolve remaining wax. The device can
now be removed from the acetone bath and allowed to dry. If visible traces of wax remain on the
device surface, it should be immersed in fresh acetone for another 5 minutes while stirring.

Figure 4.1: Polishing set up for CNT arrays
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4.1.1 Effect of Polishing Time:
The AAO template does not have pores with a constant diameter through the cross section. The diameter
of pores varies along the thickness of the membrane. This is illustrated in Fig. 3.10. With an increase in
polishing time, it was hypothesized the diameters of exposed CNTs can be controlled due to an increased
removal of template material and exposure of wider or narrower pores.
Experiment:
AAO membranes without carbon on them were mounted on aluminum stubs using 7071 Blanchard wax
acquired from Stronghold Wax Company. They were then polished for time periods ranging from 5
minutes to 30 minutes in increments of 5 minutes using Struers DiaPro 1µm polishing suspension.
Membranes were then etched in 1M NaOH for 3 minutes to clear polishing debris from the surface and
expose pores while minimizing the effect of pore widening. They were then sputter coated for 3.5 minutes
with Pd/Au to prepare for SEM imaging. Imaging was carried out on Tescan Mira 3 FESEM, 20kV gun
voltage and 9mm working distance. All images were captured at a magnification of 40kx.
Measurement of pore sizes was carried out using NIH ImageJ. Images were adjusted for threshold and
4 𝐴𝑟𝑒𝑎

pore areas and perimeter recorded. Hydraulic diameter was calculated using the equation H= 𝑃𝑒𝑟𝑖𝑚𝑒𝑡𝑒𝑟.
Depending upon the number of pores in an image, between 700-800 measurements were taken from each
image. 2 images from different regions of the same membrane were analyzed.
Results:
Figure 4.2 shows SEM micrographs of the membranes after polishing and wet etching. The dark and light
bands on the edges are caused due to charge build up during imaging. Visually, the pores appear to have
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Figure 4.2: Membranes polished at 30N for (A) 5minutes (B) 10 minutes (C) 15 minutes (D)
20 minutes (E) 25 minutes (F) 30 minutes, scale bar 2µm
been perfectly exposed with no sign of the lattice layer. The graphs in Fig. 4.3 show average pore size and
pore size distribution for each of the specimens.
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Figure 4.3a: Variation of pore hydraulic diameter with increasing polishing time at 30N (A) 5
min (B) 10 min (C) 15 min
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Figure 4.3(b): Variation of pore hydraulic diameter with increasing polishing time
(D) 20 min (E) 25 min (F) 30 min
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Figure 4.4: Change in Hydraulic Diameter with Polishing Time. Error bars show SD.
Observations and conclusions:
From the above data, a slight
decrease in the average pore size is
observed with increase in polishing
time. This suggests that after just 5
minutes, the membrane has been
polished to expose pores higher than
Figure 4.5: Cross section view of membrane showing
region exposed by polishing in blue. Not to scale

250nm in diameter and as polishing
continues, a decrease in pore size
can be observed. This indicates that

polishing is taking place within the ‘neck’ area of the pores, after the lattice layer. The error bars indicate
the standard deviation of pore sizes within a sample. The standard error value indicates that there is
significant difference between pore sizes when polishing time is raised from 5 minutes to 10 minute and
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further on to 20 minutes. There is no increase in the hydraulic diameter with polishing, suggesting that
material is not removed to more than a few microns below the lattice layer as shown in fig. 4.5.

4.1.2 Effect of Polishing force
The geometry of pores through the AAO membrane cross section has been well documented by (Golshadi
2016). The pores are shown to have a vase like geometry beyond the lattice layer, starting with a wide
opening leading to a narrower neck and a wider body, depicted in Fig. 4.5. It can be deduced that by
controlling the depth to which the membrane is polished, exposed CNT diameters can be controlled. The
depth of polishing could be controlled by either polishing at a higher force or polishing for longer times.
In this experiment, AAO membranes were exposed to 7 hours of CVD at 705 °C. Membranes were then
polished for 5 minutes using the DiaPro 1µm diamond suspension at 10N, 30N and 50N. membranes
were then wet etched in 1M NaOH for 5 minutes at room temperature. SEM imaging was carried out
using the Mira TESCAN FESEM at a beam voltage of 20kV. The hydraulic diameter of the tube lumen
was calculated using ImageJ particle analysis tool. Area and perimeter of pores were recorded and
4 𝐴𝑟𝑒𝑎

hydraulic diameter calculated as 𝑃𝑒𝑟𝑖𝑚𝑒𝑡𝑒𝑟 . 2 images from difference regions on each membrane were
analyzed and Students t-test assuming equal variance was used to make sure that the difference in data
from the 2 images was not statistically significant. Fig. 4.6 shows the images used for analysis followed
by graphs in Fig. 4.7 showing the distribution of CNT inner diameters.

Figure 4.6: Top down view SEM micrographs of CNT arrays after polishing at (A) 10N (B)
30N (C) 50N Scale bar 2µm
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Observations and conclusions:

Figure 4.7: Variation of inner hydraulic diameter of CNT with polishing force after 5 minutes
of polishing (A) 10N (B) 30N (C) 50N
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Recordings of tube diameters from the same membrane on different regions of the membrane were not
statistically different from each other indicating that the polishing process could result in even polishing
across the surface. There was little difference observed between the CNT inner diameters between
devices polished with different forces, strongly suggesting that increasing force does not necessarily
increase the depth to which polishing occurs. With increased polishing force, the membranes were found
to be more likely to curl during the etching step, likely due to increased internal stresses. Increasing the
polishing force also increased the likelihood that a membrane could get stripped off the polishing stub or
develop cracks, thus compromising its functionality or leading to a complete loss. Therefore, a polishing
force of not more than 30N was considered ideal for the process while keeping time as the variable
parameter to adjust depth of polishing.

4.2 Wet Etching:
The aluminum oxide template used is an amphoteric oxide, soluble in both acids and bases. Wet etching
of aluminum oxide is commonly carried out using NaOH or H3PO4. In this section, the effect of etching
time and etchant molarity upon CNT height is discussed.

4.2.1 Effect of etchant concentration:
To better understand etch rates with respect to changing concentration etchants, CNT array devices were
etched with NaOH ranging from 1M to 9M concentration after polishing for 5 minutes at 30N. CNT
height measurements were carried out manually using ImageJ on SEM micrographs captured at 35° stage
tilt. 200 data points were recorded from each image. Fig. 4.8 shows the qualitative change in array
devices with increasing molarity of etchant. Pore widening is observed to be the limiting factor for tube
heights when wet etching is used. Tube height distribution is shown in Fig. 4.9.
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Results and Observations:

Figure 4.8: 35° tilt micrographs of CNT array devices etched with NaOH (A) 1M (B) 2M (C)
3M (D) 5M (E) 7M (F) 9M Inlets showing top down view and pore widening. Scale bar 2µm,
inlet scale bar 1µm
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Figure 4.9: CNT height distribution after etching 5 minutes with NaOH (A) 1M (B) 2M (C) 3M
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Figure 4.9(b): CNT height distribution after etching 5 minutes with NaOH (D) 5M (E) 7M (F)
9M
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Figure 4.10: Mean CNT height after etching for 5 minutes with varying NaOH
A consistent increase is observed in the CNTconcentrations
heights up to 3M concentration, as seen in fig. 4.10. The
regime between 3M and 7M concentration does not show significant difference in tube heights. This is
attributed to the isotropic nature of wet etching and resulting pore widening. Both the edges around the
tubes and the bulk of the membrane experience the same etch rates. However, there is much lesser
material to etch at the edges as compared to the bulk. Therefore, in a given amount of time, more of the
edge gets etched, leading to a rapid widening of the pore instead of uniform top-down etching.
Pore widening poses the risk of CNTs losing their structural support from the template and potentially
clumping, if excess etching is carried out. It also adds ambiguity to the measurement of CNT heights
because the actual point of intersection between the template surface plane through the CNT cannot be
identified. Thus, CNT measurements from devices with significant pore widening cannot be accurately
judged.

4.3 Conclusion
Polishing and wet etching can be controlled to yield CNT arrays of desirable physical parameters in a
fraction of the time as compared to reactive ion etching. A typical polishing process will take 10 minutes
of process time to yield 6 membranes compared to 6 hours for RIE. Thus, polishing and wet etching are
significantly quicker and cheaper processes.
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Chapter 5: CNT Quality Control
CNTs fabricated through polishing and wet etching display quality issues unique to the polishing process.
Polishing, being an abrasive process, poses the risk of damaging CNT arrays due cracks induced in the
template during the process, uneven polishing due to improper mounting of CNT devices on polishing
stub and microscale damage to CNTs from polishing particles. This chapter presents a qualitative
assessment of CNT arrays using electron microscopy as the primary investigative tool. All SEM
micrographs were captures on the TESCAN Mira3 FESEM, with an accelerating voltage of 20kV unless
mentioned otherwise.
5.1 Clogging of CNTs

Figure 5.1: SEM micrographs of CNT arrays showing possible clogging (A) Type 1: Highly
clogged and damaged, white circles show clogging in tubes (B) Type 2: Light clogging and
minimal damage (C) Type 3: No clogging, no damage. Scale 500nm

As seen in Fig. 4.1 earlier, the polishing set up consists of a number of materials which are directly
involved in contact with the polishing pad and may lead to clogging of nanotubes. Clogging throughout
this chapter is classified as 3 types, shown in fig. 5.1. Type 1 clogging indicates highly clogged pores
which are often found alongside damaged tubes. Type 2 clogging is less compared to type 1 and less tube
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damage is observed. Type 3 indicates well formed, unclogged CNTs with no damage. The presence of
obstructions in CNTs can be undesirable if CNT devices are used for fluidic applications such as
intracellular delivery or as a component of a microfluidic system. In order to understand the cause of
clogging and methods to eliminate it, a number of experiments were carried out.
Membranes during polishing come in contact with several materials. Blanchard holding wax, a commonly
used wax for polishing silicon wafers in the microchips industry, is used to hold the AAO membranes
onto the polishing stubs machined out of aluminum. The polishing pad used is a Struers MD FLOC nonwoven fiber pad. Polishing slurries used were 1µm, ¼ µm Struers DiaPro (Diamond) and 0.05µm alumina
(powder suspended in water). With the above set up, 4 major elements can be identified as the potential
source of clogging in CNT arrays:
•

Diamond – from polishing suspension

•

Wax – Used to hold the devices on the stub

•

Alumina

•

Carbon – from CNT devices
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5.1.1 Identification of clogging source - Wax
Initial hypothesis suggested that due to improper
cleaning, residual wax was responsible for clogging
the CNTs. This problem was not observed when plain
membranes were polished with or without wax
suggesting that the decreased diameter of lumen after
carbon deposition was affecting the ability of acetone
to completely remove wax. Since wax is soluble in
acetone, longer acetone wash times, higher
Figure 5.2: Bare membrane polished for
5 minutes, 30N. No clogging observed.
Scale 2µ

temperatures and ultrasonication in acetone were
experimented with to understand its effect on
clogging. Fig. 5.3 shows the results after the different
rinsing processes.

Figure 5.3: Top down micrographs of CNT arrays after (A) rinsing in acetone (40°C) (B)
Rinsing in water (100°C) (C) After forcing acetone through CNTs using syringe. Type 2
clogging observed in all specimens. Scale 1µm
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In the images shown in Fig. 5.3, it can be observed that clogging is persistent in all CNT devices despite
the processing technique utilized. These experiments indicated that the hypotheses of wax clogging the
nanotubes was likely to be a weak hypothesis and other causes should be considered. However, the
experiments did not indicate a complete breakdown of the hypothesis since it could not be confirmed
whether the acetone was truly effective at dissolving wax from the CNTs. Thus, these experiments
assumed that acetone is 100% effective at dissolving all wax. To confirm the hypothesis, polishing was
carried out without using wax as a mounting agent for 5 minutes and 30N followed by 5 minutes of
etching with 1M NaOH. CNT arrays were mounted using Kapton tape on to aluminum stubs and
polished. The resulting micrographs, shown in fig. 5.4, showed type 1 clogging in the CNTs, thereby
confirming the hypothesis that wax was not
responsible for clogging the CNTs.

5.1.2 Identification of Clogging Source –
Aluminum Oxide
Aluminum oxide, if involved in clogging the
CNTs, should ideally have been dissolved by
the action of wet etchants such as NaOH or
phosphoric acid. It is possible that due to the
small diameters of CNTs, etchants were not
Figure 5.4: Top down micrograph of CNT array,

able to access the lumen and dissolve the

polished without wax, 5mins, 30N. Clogged
tubes encircled.

alumina.
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To overcome this, X-ray microanalysis using scanning electron microscopy (SEM) was utilized.

Figure 5.5: EDX spectra overlay - showing aluminum in red. Clogged pore circled. Red color
suggests presence of aluminum

The image in Fig. 5.5 strongly suggests that alumina is present in some quantities in the clogged pores. It
must be noted that EDX results cannot be taken as conclusive but were used as a guide for future
experiments. To eliminate traces of alumina from the clogging, devices were exposed to reactive ion
etching using BCl3 and wet etching techniques. It was expected that BCl3 will result in selective etching of
AAO and a reduction in clogging can be observed.

Figure 5.6: Top down micrographs of CNT devices processed with RIE for (A) 15 minutes
(B) 30 minutes (C) 45 minutes followed by wet etching for 5 minutes with 1M NaOH. A, B
show type 2 clogging and C shows type 3 clogging. Scale 1µ
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Reactive ion etching was carried out for 15, 30 and 45 minutes at a flow rate of 20SCCM argon and
80SCCM BCl3 on different devices immediately after polishing. The devices were then subject to wet
etching with 1M NaOH for 5 minutes. It was expected that reactive ion etching will selectively etch away
aluminum oxide, thereby unclogging the tubes to some degree. The images in Fig. 5.6 show that RIE has
influenced the clogging of CNT arrays but type 1 clogging is seen in Fig. 5.6 (C) and type 2 in panels A,
B. The devices used for this batch of experiments also show some variability in polishing but clogging is
observed in all sections of the devices irrespective of the quality of polishing. Further experiments were
carried out using by using variations of wet etching.
In Fig. 5.7, all devices were etched using 1M NaOH for 5 minutes unless specified. Significant etching
has taken place when using higher concentration of NaOH or warm NaOH, indicated by the presence of

Figure 5.7: Top down micrographs of CNT devices etched with (A) 7M NaOH for 5 minutes
(B) 9M NaOH for 5 minutes (C) 1M NaOH for 5 minutes followed by 0.1M NaOH for 5
minutes (D) 1M NaOH, ~40°C, 5 minutes, Scale 1µ
pore widening. However, clogging is still observed in the CNTs. With the increase in NaOH
concentration, an increase in the viscosity and surface tension of solution is observed. To enable better
access to the CNT lumen, a lower molarity of NaOH was used to etch the device for a second round.
Using a lower molarity of NaOH for a second round of etching after 5 minutes of etching with 1M NaOH
also did not show any reduction in clogging.
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5.1.3 Identification of Clogging: Carbon
Since all the methods above selectively dissolve or etch away aluminum oxide, it could be concurred that
aluminum oxide was not the primary element responsible for clogging of CNTs because there appeared to
be negligible change in the number of clogged CNTs in each experiment. This in conclusion implied that
the clogging was most likely being caused by carbon being smeared from damaged CNTs during the
polishing process.
In order to confirm the hypothesis, attempts were made to oxidize carbon using oxygen plasma etching.
The 2 routes to eliminate carbon from the polishing process are shown in Fig. 5.8 below. In route A,
carbon is etched away prior to polishing and therefore is not involved in the polishing process,
eliminating any possibility of it clogging the CNTs. In route B, carbon is etched after CNTs have been
exposed. In an ideally controlled process, just the right amount of etching would take place to eliminate
the clogging. In the case of excessive etching, the CNT array could be further wet etched to dissolve more
of the membrane and re-expose nanotubes. Since, neither of the processes provide an advantage over the
other, the selection criteria were limited to the route which would offer better control over the geometry
of CNT array device.
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Figure 5.8: Schematic depicting two methods of implementing oxygen plasma to remove
carbon (A) O2 plasma is used to eliminate carbon from the polishing process (B) O2 plasma is
used to etch the top of CNTs which can then be exposed again by etching

In Fig. 5.9 below, results from method A are shown. Initially oxygen plasma (SAMCO RIE-1C) was
carried out for 2 and 4 minutes at 50SCCM flow rate and 200W RF power on carbon coated membranes
prior to polishing. The devices were then polished for 25 minutes at 30N and etched in 1M NaOH for 5,
8minutes. It is seen that carbon is completely etched off in some regions from the membranes and no
clogging is observed. Plasma treatment therefore resulted in excessive etching. To better control the
process, oxygen plasma was carried at 50W and 50SCCM on carbon coated devices and followed by 25
minutes of polishing at 30N 5, 7 minutes of etching in 1M NaOH. In fig. 5.10 (A, B) are images from 2
different membranes. (A) displays clogging while minimal tubes are observed in (B). Since the etch rate
of amorphous carbon within the geometry of porous membrane is not documented, it was not possible to
estimate the depth to which carbon was being etched. From 5.10 (A, B) it is clear that the process presents
variability. Owing to the above factors, it was decided to try route B shown in fig. 5.8.
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Figure 5.9: SEM micrographs of devices after O2 plasma at 50SCCM, 200W (A) 2 minutes
(B) 4 minutes followed by polishing for 25 minutes at 30N and wet etching for (A) 5 minutes
(B) 8 minutes. Scale 2µm

Figure 5.10: CNT arrays fabricated using procedure outlined in fig. 6.8 (A). O2 plasma
carried out at 50SCCM, 50W for 1 minute followed by polishing for 25 minutes, 30N (A, B)
Wet etched 3 minutes (C) 7 minutes with 1M NaOH. Scale 2µm
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We observe that despite the layer of debris from polishing, oxygen plasma significantly reduced clogging
in the carbon nanotubes. With increasing oxygen plasma time, the number of unclogged pores increases
significantly. The removal of clogging appears to be a relatively quick process since pores are observed
with clogged CNTs or completely clean. This gives strong evidence for the hypothesis that clogging is
caused primarily due to carbon.
Figure 5.11: Devices polished for 5 minutes, 30N followed by wet etching for 5 minutes with
1M NaOH. O2 plasma carried out for (A) 60s (B) 90s (C) 120s at 50W, 50SCCM flow rate
followed by etching again for 5 minutes with 1M NaOH. Scale (A) 1µm (B) ½ µm (C) 1 µm

Oxygen plasma was also carried out on polished devices after etching, to understand whether the process
of eliminating clogging could be controlled when nanotubes are exposed. Fig. 5.11 shows the resulting
devices after 60, 90, 120 seconds of oxygen plasma at 50W, 50SCCM of oxygen flow. The devices were
etched again in NaOH after oxygen plasma to increase the length of exposed tubes. After 1 minute of
treatment with oxygen plasma, seen in Fig. 5.11 A (i), certain regions of the membranes show excessive
etching and no tubes are observed. In Fig. 5.11 (A (ii)) clogged tubes of type I are observed. After 2
minutes of treatment and more, almost all carbon is etched away and no nanotubes are observed on the
surface, implying excessive etching.
Although oxygen plasma treatments were successful to a limited extent in helping unclog the CNT
devices, a high level of variability and lack of control made the use of O2 plasma unfeasible.
Corona plasma treatment was also briefly explored as an aid to unclog the CNT arrays. A corona
discharge is formed when a highly charged conductor ionizes the insulating fluid around it, in most cases
this fluid is air. The corona discharge will result in the production of ozone and other ions. A handheld
corona discharge device known as the plasma wand was used for this task. Since CNT devices are
conductive, an arc was formed between the conducting tip of the corona device and CNT device.
Membranes were treated either before etching or after etching for 30s and 120s. Fig. 5.12 shows the
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results of the experiment. In Fig. 5.12 (A, C) we can see that corona treatment immediately after polishing
for 30 seconds does not result in a significant reduction in the clogging of carbon nanotubes in some
region while other regions show a complete elimination of nanotubes. After 120s of corona treatment,
CNTs have been etched and bare AAO can be observed. The process exhibits a high amount of localized
variability.

5.2: Effect of CVD Time and Membrane Position in Furnace on CNTs
It was found that the position of membranes on the CVD holder, referred to as the ‘boat’ and CVD time
had a major effect on the clogging of CNT arrays. The following experiments were carried out to
qualitatively observe how CVD time and membrane placement affects CNT quality.

Figure 5.12: Plasma wand used before etching (A) 30s (B) 120s, Plasma wand used after
etching (C) 30s (D) 120s, followed by etching for 1 minute with 1M NaOH. Scale 1µm, (C)
scale 500nm
Experiment 1:
The CVD boat consists of 35 slots, of which 9 were filled as shown in fig. 5.13. The membranes were put
through CVD for 5 hours and 7 hours. Membranes were then taken in groups of three, depending on their
position in the boat (near gas inlet, center, near exhaust). 1 membrane in each group was polished with
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15N force for 5 minutes while the other two in the group were polished at 30N for 5 minutes followed by
5 minutes of wet etching with 1M NaOH. The results are shown in fig. 5.14 and 5.15 below.

Figure 5.13: Arrangement of membranes to study CNT quality changes due to position in
tube furnace and CVD time

Figure 5.14: SEM micrographs of 5-hour CVD (A, C, E) 15N 5 min polished devices (B, D,
F) 30N 5 min polished devices (A, B) near exhaust (C, D) center (E, F) near inlet. Scale 2µm

84

Figure 5.15: SEM micrographs of 7-hour CVD (A, C, E) 15N 5 min polished devices (B, D,
F) 30N 5 min polished devices (A, B) near exhaust (C, D) center (E, F) near inlet. Scale 2µm
The position of devices in the polishing equipment
holder was also tracked to rule out any variability
due to the polishing set up.
Results: It was observed that after 5 hours of CVD,
irrespective of polishing force, CNTs were easily
damaged during the polishing process and appeared
to be clogged. CNT wall thicknesses appear to be
consistent across all samples indicating uniform
carbon deposition. After 7 hours of CVD, an
interesting observation was made. Specimens closer

Figure 5.16: Unclogged, undamaged tubes
after 7 hours CVD. Device was placed near
exhaust during CVD. Scale 1000nm

to the exhaust seem to have lesser clogging in the
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tubes and displayed lower tube damage, despite equivalent tube wall thicknesses. This experiment was
repeated to confirm results, seen in fig. 5.16.

Figure 5.17: Experimental set up to study variation in CNT quality after polishing due to
membrane positioning in sample holder and interdependence of membranes in different
positions. CVD carried out for 7 hours

Figure 5.18: Membranes imaged corresponding experiments described by fig. 6.17. (A)
Type 1 clogging observed in all samples (B) No clogging in one sample (shown here). Inlet
shows tube damage (C) Type 2 clogging observed. All specimens imaged were from the
group near the exhaust. Scale 2µm (A, B scale is the same), (B inlet) 200nm
86

A third experiment was designed to study whether the removal of membranes from other positions in the
boat would yield similar results. In this experimental set up the boat was filled with membranes as shown
in figure 5.17. The membranes were then exposed to 7 hours of CVD and polishing at 30N for 5 minutes
using 1µm diamond slurry followed by etching using 1M NaOH for 5 minutes. Fig. 5.18 shows the results
of this experiment. Only the marked membrane showed unclogged tubes. This result strongly suggested
an interdependence of membranes in different positions with respect to how devices reacted to polishing.

Figure 5.19: Cross section view of membranes (A) No clogging is observed in the tubes
below the surface (B) Unclogged membrane, no clogging in tubes below surface. Thus,
clogging is only on the surface. Scale (A) 1µ (B) 2µ

To verify that CNTs were unclogged all the way through, cross section of etched, broken membranes was
imaged. In Fig. 5.19, the CNTs show no clogging, neither at the upper opening of the CNTs nor in the
lower sections. In the clogged CNT arrays, it is seen that the clogging does not extend down below the
very top, implying that there are no impurities that remain in the tubes from the polishing process. This is
an important observation since the presence of impurities within the nanotubes would pose larger
problems for the purposes of cleansing as compared to impurities at the very openings.
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Although unclogged CNTs could be obtained
by the above-mentioned method, it added
time to the process while reducing yield by
50% because only 3 membranes at a time
could be obtained unclogged. Unclogged
membranes also displayed signs of tube
damage and jugged CNT walls as shown in
fig. 5.20.
The issue of clogging was also studied with
respect to the grain size of polishing slurry
Figure 5.20: Arrows showing jagged tube walls

used. The following solutions were available

for use:
1. Struers DiaPro Nap 1µm
2. Struers DiaPro Nap ¼ µm

Figure 5.21: 35° tilt micrographs of CNT arrays polished using (A) 50nm Alumina for 5 minutes
at 30N, inlet shows top down view of tubes (B) ¼ µ DiaPro for 5 minutes, 30N, inlet shows top
down view. Scale (A) 2µ, inlet 500nm (B) 1µ, inlet 250nm
88

3. Electron Microscopy Sciences: Type DX alpha alumina powder 0.05µm
The Struers acquired suspensions are proprietary suspensions of mono-crystalline diamonds, coolant and
lubricant to minimize heat generation during the process and increase the life of the polishing pad. The
Alumina powder was mixed with water or Struers proprietary DP Green Lubricant. Results of polishing
from the different suspensions are shown in Fig. 5.21. A marked observation is that the reduction in
suspension size has a marked increase upon the smoothness of tube walls and reduction of clogging
within CNTs. The DX alpha alumina powder shows the best results with respect to clogging, however,
due to the lack of lubrication, coolant and imperfect concentration of particles, accelerated polishing pad
wear was observed along with increased damage to membranes during the polishing process.
In conclusion, alternative processes of fabrication have been developed which can produce CNT arrays of
quality comparable to CNT arrays produced via dry etching in a fraction of the time. The use of smaller
suspension particles for polishing results in increased coplanarity of tubes and decrease in clogging of
CNTs.
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Chapter 6: Cell Culture on CNT arrays and Transfection
To confirm that CNT array devices were
ready for use with cell transfection, basic
fluid flow experiments were carried out.
These experiments were not designed to
quantify fluid flow parameters through
nanotubes but rather to confirm that flow of
fluid was possible through the devices. The
experiment was set up as follows.
Devices were placed cell growth side down
on a sheet of paper and a drop of DI water
was placed on the device. The device was
covered to prevent evaporation of the drop.
After 2 hours, wetting of paper under the
device confirmed that water had gone
Figure 6.1: (A) Devices placed on dry paper with
water droplet (B) wetting observed under device
after 2 hours, confirming fluid flow capability

through the CNT array, depicted in Fig. 6.1
below.

6.1 Cell culture – Experiment 1: 3T3 Cell Growth on CNT arrays
The first experiment to study cell growth was carried out on devices that had been exposed to 3 minutes
of oxygen plasma at 300 mTorr, 250W RF power and 100 sccm of oxygen flow. The devices were then
wet etched using 1M NaOH for 15, 17 and 20 minutes. The aim of this experiment was to understand
basic cell culture protocols and handling of equipment in a tissue culture room.
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Cells used were of the NIH/3T3 type fibroblasts. Cells were detached from cell flask by letting them sit in
trypsin for 7 minutes. Trypsin was aspirated and Dulbecco’s Modified Eagle’s Medium (DMEM) was
added to neutralize the effects of trypsin. 20µl of cells in media was taken and dyed blue with 20µl of
trypan blue to identify dead cells. 0.5µl of cells was put into a hemocytometer for counting. Each device
was to be coated with 40,000 cells which was calculated as approximately 500µl.
2 of 17 minute and 15-minute etched devices each were coated with cells. Devices were rinsed with
ethanol prior to use. The devices were left to dry for 5 minutes and PBS used to rinse devices to remove
leftover ethanol if any. 0.5ml of cell solution was added to each well and allowed to incubate for 24
hours. To observe cells under a microscope, they were fixed using paraformaldehyde diluted in PBS
(unknown concentration) and stained with a green actin filament dye. Images in Fig. 6.2 show cells
growing on the devices.
The images in Fig. 6.2 show that cells
adhered to the surface of the CNT array
device and appear to be healthy as per their
morphology.

Figure 6.2: Fluorescent image of fixed 3T3 cells
on CNT array etched for 17 minutes with 1M
NaOH (A) 20x (B) 100x

6.2 Cell Culture – Experiment 2: HE293 Cell growth and EYFP transfection attempt
HEK 293 cells were cultured on CNT array devices fabricated using mechanical polishing. Devices were
fabricated by carrying out CVD for 5 hours followed by polishing for 5 minutes at 30N of force using
DiaPro 1µm diamond suspension. The devices were then etched using 1M NaOH for 3 minutes, 5
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minutes and 7 minutes. The CNT heights were measured as 104 ± 30nm, 114±30nm and 134±39nm for 3
min, 5 min and 7 min etched devices respectively. The distribution of tube heights can be seen in fig. 6.3.

Figure 6.3: CNT height distribution after etching with 1M
NaOH (A) 3 min (B) 5 min (C) 7 min
48,000 cells were added to each device as a drop on the CNT devices facing cell growth side up. The cells
were allowed to adhere onto the device for 2 hours. 1ml of DMEM was added to the wells and cells
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allowed to incubate for 48 hours. Cells were stained using Calcein AM green to view under fluorescent
microscope. Confluency was observed ranging between 50-70% on different locations of the devices.
This can be seen in fig. 6.4 below.

Figure 6.4: HEK293 cells harvested after 48 hours from CNT arrays (A) from 3 min etched
device (B) from 5 min etched device (C) from 7 min etched device
The devices were then transferred to the transfection set up shown in Fig. 6 and transfection was
attempted using Venus Enhanced Yellow Fluorescent Protein (EYFP). EYFP was prepared by adding
36µl of Venus DNA in 600µl of patch clamp buffer. 100µl of DNA was added to each device and they
were allowed to incubate for 2 hours.
Cells were harvested from device using trypsin after 2 hours and transferred to tissue culture plastic. They
were allowed to incubate for 24 hours and then viewed under a fluorescent microscope. The cells were
found to show no fluorescent activity and it could be concluded that transfection was not successful. The
cause of failure was hypothesized as a combination of multiple issues. As seen in Fig. 3, the devices can
be seen to possess clogging within nanotubes. CNTs were also observed to have peaks and jagged edges
unlike the smooth coplanar surfaces of devices fabricated through RIE. In order to increase chances of
success, the above issues were addressed in preparation for the next experiment.

6.3 Cell Culture – Experiment 3: HEK293 Cell growth and EYFP transfection attempt
HEK 293 cells were cultured on arrays devices fabricated via 7 hours of CVD followed by polishing for 5
minutes at 30N. Devices were etched using 1M NaOH for 5 minutes and 7.5 minutes. As mentioned in
Chapter 6, this method of fabrication resulted in unclogged CNTs. 5 devices were used for this
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experiment. 3 were etched for 5 minutes and 2 were etched for 7.5 minutes. Devices were coated with
48,000 cells and allowed to incubate for 2.5 hours. 2ml of DMEM was added to each of the 5 wells
containing CNT devices after 2.5 hours and 1 ml of DMEM was added to the control well in a 24-well
plate. Cells were dyed red using CellTracker CMTPX. Dye was prepared by adding 50µg of CellTracker
red to 70µl of Dimethyl Sulfoxide (DMSO). 2µl dye was added to 2ml of media in 6 well plates and
allowed to sit for 30 minutes. Cells were then viewed under a rhodamine filter and had appeared to have
achieved confluency of 90%. Lipofection was used for the control experiment. 50µl Jet Prime buffer was
mixed with 1µl jet prime reagent and 0.5µg of Venus YFP. Control well media was aspirated and 0.5ml
of fresh media added and the lipofection solution added. For transfection using CNT devices, 600µl patch
clamp buffer was mixed with 36µl Venus DNA. Each device received 100µl of Venus DNA solution.
Devices were pulled out of the incubator after 2.5 hours and transferred to new well plates. They were
viewed again under the rhodamine filter and appeared to be confluent. It should be noted at this point that
the microscope was not equipped with a camera and thus images were not acquired. Devices were washed
with trypsin and cells were transferred to 6 well plates, allowed to incubate for 24 hours. Very few cells
were observed after 24 hours and no fluorescence was observed either. In contrast, the control well cells
fluoresced bright yellow. This indicated another failure in transfection. The leading cause for this failure
was identified as mishandling when cells were harvested from CNT array devices to well plates after
transfection. Also, cells were plated on the device for only 24 hours prior to transfection. According to
Golshadi, the time that cells were allowed to grow on devices prior to transfection had a significant
impact on transfection efficiency. The low concentration of DNA was as also cited as a major reason for
lack of fluorescence. Transfection using CNT array device requires a much higher concentration of DNA
as compared to lipofection.
In parallel with this experiment, the following set up was also tested for transfection. Fig. 6.5 shows a
Whatman paper which has been wetted with DMEM. Instead of laying CNT devices on cylinders, the
device was laid down cell side down on the Whatman paper. Protocols for cell culture, dye preparation
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and DNA preparation followed were the same as above in this experiment. Cells were transfected in the
same method as above. Cells were found to adhere well to the device and did not adhere to the Whatman
paper. However, no transfection was observed. This method has potential for reducing device damage and
improve ease of handling during the transfection process.

Figure 6.5: Set up for transfection using Whatman paper
Keeping in mind the above-mentioned drawbacks, the next cell culture experiment was carried out using
propidium iodide (PI), a cell impermeable dye and cells allowed to culture for 48 hours.

6.4 Cell culture – Experiment 4: HEK293 Cell Growth, PI injection
3 devices were used for this cell culture experiment. The devices were exposed to CVD for 7 hours,
followed by 5 minutes of polishing at 30N using 1µm DiaPro diamond suspension. The devices were then
wet etched for 5 minutes and 7.5 minutes with 1M NaOH. Each device came from 3 distinct regions of
the boat. Calcein AM purple was used to stain cells for fluorescence and Propidium Iodide was used as
cargo for delivery inside cells. Calcein Purple was created by adding 42µl of sterile DMSO to 25µg of
dye. 40µl of this solution was added to 1250µl of buffer to create 200x working solution. For 6 wells, at
1ml per well, 30µl of working solution was needed. Propidium Iodide was used at 75µm concentration in
patch clamp buffer (PCB). A 100x stock solution was made by adding 5mg of PI per 1ml of PBS.
Therefore, the final solution required 300µl of PCB in 3µl of 100x PI.
Each device was coated with 24,000 cells by placing a 100µl drop of cells in media on the top surface of
device. The cells were then allowed to attach for 2 hours on the surface in an incubator and 2ml of media
was added to each well with the devices. Cells were allowed to incubate for 48 hours before transfection.
Due to a handling error, excess PI was added on the devices, leading to quick cell death since high
concentrations of PI can be toxic to cells. Transfection data was thus not obtained. PI was seen to have
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been transferred to through CNTs. After only a small number of cells could be harvested from the device
again.
A critical observation from the above experiments was the small number of cells harvested after
transfection from CNT devices. This lead to re-evaluation of the experimental set up and identification of
potential problems.

Figure 6.6: Schematic showing steps involved in transfection process (A) Cell adherence
by placing a drop of cells on device (2 hours) (B) Adding media to let cells grow (48 hours)
(C) Placing device upside down in cylinder, cell side in DMEM, cargo placed on top (2
hours)

Fig. 6.6 shows the handling and manipulation required throughout the process. CNT arrays are first
placed in a 6 well plate and sterilized using ethanol. The ethanol is allowed to dry, followed by rinsing
with PBS. A 100-150µl drop of media containing the required number of cells is placed on the device.
This is preferred over immersing the device in 1-2ml of media with cells to prevent cells from adhering
and growing on the underside of the device where cargo to be transfected will be placed. Cells are
allowed 2 hours to adhere on to the surface before each well is filled with 1-2ml of media and left to
incubate for 24-48 hours. Devices are then transferred into the transfection set up. Each cylinder in is
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filled with 150µl of fresh media and device is placed such that the cell adherent surface is immersed in
media. A drop of solution (PCB or DMSO) containing the required cargo is placed on the other side of
the device with great care to prevent the drop from breaking and leaking into the media or sliding off the
device. The set-up is placed in the incubator for 2 hours. After this step, devices are washed with PBS and
cells trypsinized. The cells are then transferred to a new 6 well plate with 1-2ml of media and allowed to
incubate for 24 hours to show transfection.
In the above protocol, the first step of attaching cells to the device is rife with ambiguity about cells
adhering to the CNT surface. Golshadi et. al had immersed CNT devices in media for 24 hours to allow
cells to grow on the device. However, this poses the risk of cells growing on the bottom surface too.
Moreover, due to the extremely smooth surface finish of polished CNT arrays, it is difficult to make sure
that the drop of cells in media remains completely upon the device and much of it can slide off with ease.
This can potentially lead to a loss of cells on the device. With a thin layer of cells on the device and high
variability in confluency, it is likely that the cargo takes the path of least resistance like any other fluid
flow system, allowing cargo to leach into the media below.

6.5 3D Printed Nanofluidic Device
Whatman Anodisc 13 alumina membranes are 60µm in thickness. This results in extreme fragility and in
turn results in easy loss of devices by cracking during handling and manipulations carried out during
experiments. In order to ease handling of the CNT devices, three-dimensional (3D) printing was used to
create a support structure for the membranes. 3D printing was utilized to encapsulate the CNT array in a
microfluidic device. In Fig. 6.7 shows the geometry of the proposed structure and different sizes of rings
printed around a bare AAO membrane.
The 3D printed rings around CNT devices served multiple purposes during the course of culturing
cells and subsequent transfection. Apart from developing cracks or due to handling errors in dry
conditions, during the production of devices, CNT devices were found to adhere to wet surfaces due to
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surface tension. This required very delicate handling, which was operator dependent and could not be
standardized for large-scale use. This problem was further exacerbated when the liquid in question was of
higher viscosity as is commonly observed in with growth media in cell culture or wet etchants during
production such as phosphoric acid (H3PO4). This lead to the device being damaged when lifting off from
a wet surface while transferring from one culture dish to another. The 3D printed ring provided an uneven
surface, which easily breaks surface tension and can be easily held by tweezers while minimizing the risk
of damage to CNT device.
During the process of transfection, the ring not only could provide physical support but also serve as a
reservoir for the purpose of holding cargo to be delivered into cells. The thickness of 3D printed ring may
potentially be increased to accommodate larger volumes of reagent and this also prevents tweezer - cell
contact, thereby minimizing the risk of cell death due to any stress that might be inflicted upon them by

Figure 6.7: (A, B, C) CAD illustrations of proposed 3D printed rings (D) 3D printed
prototypes of different sizes on plain AAO membranes
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tweezers. Moreover, since the active area of the device is now defined by the inner diameter of the ring, it
provides for a more confident analysis of cell growth and transfection. This is because the edges of the
device display imperfections, which can hinder functionality.
To demonstrate cell culture on 3D printed devices, HEK 293 cells were cultured on the 3D printed
CNT array devices for 48 hours and stained with CellTracker Green to observe cell growth and
morphology. Devices were coated with Polylysine to aid in cell adhesion. Cells displayed morphology
similar to devices without support structure or standard tissue culture plastic as shown in Fig. 6.8.
The cell growth results were as expected due to the nature of the process used to fabricate the rings.
The PLA does not contact the bulk of CNT device surface during 3D printing and serves purely as a

Figure 6.8: HEK 293 cells stained with CellTracker Green on (A) standard tissue culture
plastic (B) CNT device (C) CNT device with support structure. Scale: 50 µm
holder for these devices without affecting cell culture on the surface of the device. Thus, the presence of a
support structure had no detrimental effect on cell growth.
Conclusion
It can be concluded that cells grow on CNT array devices using regular cell culture protocol. However,
more work needs to be done to establish a technique which will minimize loss of cells from the device to
maximize transfection. A 3D printed support was developed to aid in handling of device and cell culture
was demonstrated on the device.
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Chapter 7: Conclusion
7.1 Research Summary
Carbon nanotube arrays have shown the potential to be used as a device for intracellular delivery of
biomolecules of different size and charges into immortalized cell lines and also hard to transfect cells
such as stem cells, neurons and macrophages. With an increased demand for novel therapeutics which
offer features such as targeted drug delivery, personalized treatments and combination of gene therapy
and stem cell therapy, the CNT array device can potentially be an indispensable tool for the future of
medicine. Since carbon is a conductive material, this device also offers the potential of being used an
intracellular probe which can carry out single cell analysis on multiple cells simultaneously. This makes it
highly desirable for use in biomedical research applications as an aid to study cell functioning. However,
a major limiting factor for the development of this device and expansion of its use in the scientific and
medical community was the expensive and time-consuming fabrication process involved in their
manufacture. Depending upon the physical requirements of the device, the time spent in etching 8 devices
could go up to 12 hours using reactive ion etching.
In this thesis, a number of alternative nanofabrication processes have been outlined for the production of
CNT array with the aim of reducing time for production and increasing yield. An emphasis was given on
avoiding processes which required clean room facilities or plasma based processes in order to minimize
variability due to environmental and equipment based factors. This was also important to keep costs low
and enable scaling up the production of devices. Mechanical polishing, a purely physical and
economically feasible method, along with wet chemical etching were selected as an alternative to reactive
ion etching. Both processes require minimal resources and can be scaled up in a linear manner at low cost.
The effects of parameters such as polishing force, time, etching time and etchant molarity on physical
dimensions of CNT arrays were documented. It was shown that the presented alternative processes could
control CNT height distribution to a fine degree in a relatively short processing time ranging from 5-30
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minutes of polishing followed by 5-30 minutes of wet etching. Compared to the reactive ion etching
process, this implies a time saving of nearly 97%. It also has the advantage of being able to increase yield
by using equipment with a larger holding capacity since polishing and wet etching are not dependent upon
the scale of the device.
The quality of CNTs was qualitatively analyzed using scanning electron microscopy. Issues associated
with the polishing process included clogging of nanotubes, damaged tubes, cracked and broken
membranes during polishing and rough CNT wall edges. The use of process variables such as CVD time,
positioning of samples in CVD furnace tube and change in polishing particle size to control CNT quality
was shown. CNTs could be produced with clogged or unclogged tubes depending upon the need of
application.
Lastly, cell growth has been demonstrated on CNT arrays and attempts made to transfect with EYFP and
Propidium Iodide dye. Potential causes of failure and variability were identified.

7.2 Future work:
7.2.1 Future work in nanofabrication technique:
The newly developed fabrication process can save up time by up to 97%. However, a number of issues
such as variability in polishing due mounting membranes on the polishing set up and loss of devices due
to formation of cracks were identified. Future work can be carried out to refine the technique and scale up
the process. The use of alumina slurry had shown potential in producing CNTs with smooth edges,
minimal damage and no clogging. The alumina particles in turn lead to accelerated wear of the polishing
pad. Work on studying the right amount and type of polishing lubricant and coolants to be added would
be a valuable input.
Whatman Anodisc AAO membranes are extremely fragile and are easily damaged during handling over
the course of experiments. To aid in handling the device and also providing a built-in reservoir for fluid
over the device, fused deposition modeling 3D printer was used to print a ring around the CNT arrays.
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This provided the CNT array device with added rigidity and ease of handling. Future work on
incorporating more extensive 3D printed devices using CNT devices is of great interest. Development of
microfluidic chips with CNT devices can eliminate the need to for multiple handling steps during
experiments and provide a simple, sterile and disposable platform for carrying out transfection.

7.2.2 Future work in cell culture and transfection
In this thesis, only devices polished with 1µm DiaPro were used to study cell growth on CNT arrays. This
resulted in devices that were clogged with damaged tubes or CNTs with jagged walls. The presence of
variability in cells adhering to the device also was a potential issue that was identified. With respect to
cell growth, a number of parameters need to be understood such as the ideal CNT height for transfection
and cell growth, use of membranes with different pore spacing or diameters as the CVD template to study
cell growth when CNT diameters and CNT spacing changes.
The effect of time and cell growth is also not documented in depth for CNT arrays. It was noted by
Golshadi that an increase in cell culture time prior to transfection would lead to an increase in transfection
efficiency. An in-depth study to understand the correlation between transfection efficiency and culture
time can lead to interesting insights about CNT – cell interfacing. It has also been shown that stem cells
are highly sensitive to their physical surroundings. Therefore, it will be required to understand the effect
of CNT arrays on stem cell differentiation

102

REFERENCESReferences
[1] "Gene Therapy." Gene Therapy. American Medical Association. Web. 04 Mar. 2016.
[2] Hunt, K.K., Vorburger, S.A., Swisher, S.G., 2006, "Gene Therapy for Cancer," Humana
Press, Totowa, NJ, .
[3] Liu, S., Xia, Z., and Zhong, Y., 2014, "Gene Therapy in Pancreatic Cancer," World Journal
of Gastroenterology : WJG, 20(37) pp. 13343-13368.
[4] Sinn, P. L., Anthony, R. M., and McCray, J., Paul B, 2011, "Genetic Therapies for Cystic
Fibrosis Lung Disease," Human Molecular Genetics, 20(R1) pp. R86.
[5] Tebas, P., Stein, D., Tang, W. W., 2014, "Gene Editing of CCR5 in Autologous CD4 T Cells
of Persons Infected with HIV," New England Journal of Medicine, 370(10) pp. 901-910.
[6] Berkhout, B., Ertl, H.C.J., Weinberg, M.S., 2015, "Gene Therapy for HIV and Chronic
Infections," Springer New York, New York, NY, .
[7] Bennett, J., 2009, "Gene Therapy for Color Blindness," New England Journal of Medicine,
361(25) pp. 2483-2484.
[8] Kootstra, N. A., and Verma, I. M., 2003, "Gene Therapy with Viral Vectors," Annual Review
of Pharmacology and Toxicology, 43pp. 413-439.
[9] Woods, N., Muessig, A., Schmidt, M., 2003, "Lentiviral Vector Transduction of NOD/SCID
Repopulating Cells Results in Multiple Vector Integrations Per Transduced Cell: Risk of
Insertional Mutagenesis," Blood, 101(4) pp. 1284-1289.
[10] Kay, M. A., Thomas, C. E., and Ehrhardt, A., 2003, "Progress and Problems with the use of
Viral Vectors for Gene Therapy," Nature Reviews Genetics, 4(5) pp. 346-358.
[11] Walther, D. W., and Stein, U., 2012, "Viral Vectors for Gene Transfer," Drugs, 60(2) pp.
249-271.
[12] FUCHSLUGER, T., 2011, "Viral Vectors for Gene Transfer," Acta Ophthalmologica,
89(s246) pp. 0.
[13] Neumann, E., Schaefer-Ridder, M., Wang, Y., 1982, "Gene Transfer into Mouse Lyoma
Cells by Electroporation in High Electric Fields," The EMBO Journal, 1(7) pp. 841-845.
[14] Potter, H., 2001, "Transfection by Electroporation," Current Protocols in Neuroscience /
Editorial Board, Jacqueline N. Crawley ... [Et Al.], Appendix 1pp. Appendix 1E.
[15] Niidome, T., and Huang, L., 2002, "Gene Therapy Progress and Prospects: Nonviral
Vectors," Gene Therapy, 9(24) pp. 1647-1652.
103

[16] Henry, S., McAllister, D. V., Allen, M. G., 1998, "Microfabricated Microneedles: A Novel
Approach to Transdermal Drug Delivery," Journal of Pharmaceutical Sciences, 87(8) pp. 922925.
[17] Ali, R. R., 2004, "Prospects for Gene Therapy," Novartis Foundation Symposium, 255pp.
165.
[18] Li, S., and Huang, L., 2000, "Nonviral Gene Therapy: Promises and Challenges," Gene
Therapy, 7(1) pp. 31-34.
[19] Golshadi, M., and Schrlau, M. G., 2013, "Template-Based Synthesis of Aligned Carbon
Nanotube Arrays for Microfluidic and Nanofluidic Applications," ECS Transactions, 50(33) pp.
1-14.
[20] Golshadi, M., Wright, L. K., Dickerson, I. M., 2016, "High-Efficiency Gene Transfection of
Cells through Carbon Nanotube Arrays," Small, pp. n/a.
[21] Wirth, T., Parker, N., and Ylä-Herttuala, S., 2013, "History of Gene Therapy," Gene, 525(2)
pp. 162-169.
[22] Karson, E. M., 1990, "Prospects for Gene Therapy." Biology of Reproduction, 42(1) pp. 3949.
[23] ROGERS, S., and PFUDERER, P., 1968, "Use of Viruses as Carriers of Added Genetic
Information," Nature, 219(5155) pp. 749-751.
[24] Cross, D., and Burmester, J. K., 2006, "Gene Therapy for Cancer Treatment: Past, Present
and Future," Clinical Medicine and Research, 4(3) pp. 218-227.
[25] Cavazzana, M., Ribeil, J. A., Payen, E., 2014, "Outcomes of Gene Therapy for Beta
Thalassemia Major Via Transplantation of Autologous Hematopoietic Stem Cells Transduced Ex
Vivo with a Lentiviral Beta A T87Q Globin Vector," Human Gene Therapy, 25(11) pp. A22.
[26] Ylä-Herttuala, S., and Martin, J. F., 2000, "Cardiovascular Gene Therapy," The Lancet,
355(9199) pp. 213-222.
[27] Escors, D., and SpringerLink (Online service), 2012, "Lentiviral vectors and gene therapy,"
Springer, New York; Basel, .
[28] Kaiser, J., 2009, "GENE THERAPY Beta-Thalassemia Treatment Succeeds, with a Caveat,"
Science, 326(5959) pp. 1468-1469.
[29] Aubourg, P., Hacein-Bey-Abina, S., Bartholomae, C., 2011, "Hematopoietic Stem Cell
Gene Therapy with Lentiviral Vector in X-Linked Adrenoleukodystrophy," Blood, 118(21) pp.
80.
104

[30] Cavazzana-Calvo, M., Hacein-Bey, S., Basile, G. d. S., 2000, "Gene Therapy of Human
Severe Combined Immunodeficiency (SCID)-X1 Disease," Science, 288(5466) pp. 669-672.
[31] National Institutes of Health [NIH] (United States). Recombinant DNA Advisory
Committee, 2002, "NIH Report: Assessment of Adenoviral Vector Safety and Toxicity: Report
of the National Institutes of Health Recombinant DNA Advisory Committee," .
[32] Anderson, W. F., 2002, "Adenoviral Vector Safety and Toxicity," Human Gene Therapy,
13(1) pp. 1.
[33] Felgner, P. L., Gadek, T. R., Holm, M., 1987, "Lipofection: A Highly Efficient, LipidMediated DNA-Transfection Procedure," Proceedings of the National Academy of Sciences of
the United States of America, 84(21) pp. 7413-7417.
[34] C. Madeira, R. D. Mendes, S. C. Ribeiro, 2010, "Nonviral Gene Delivery to Mesenchymal
Stem Cells using Cationic Liposomes for Gene and Cell Therapy," Journal of Biomedicine and
Biotechnology, 2010pp. 735349-13.
[35] Onishi, A., Iwamoto, M., Akita, T., 2000, "Pig Cloning by Microinjection of Fetal
Fibroblast Nuclei," .
[36] Brinster, R. L., Chen, H. Y., Trumbauer, M. E., 1985, "Factors Affecting the Efficiency of
Introducing Foreign DNA into Mice by Microinjecting Eggs," Proceedings of the National
Academy of Sciences of the United States of America, 82(13) pp. 4438-4442.
[37] Kaushik, S., Hord, A. H., Denson, D. D., 2001, "Lack of Pain Associated with
Microfabricated Microneedles," Anesthesia and Analgesia, 92(2) pp. 502-504.
[38] Prausnitz, M. R., 2004, "Microneedles for Transdermal Drug Delivery," Advanced Drug
Delivery Reviews, 56(5) pp. 581-587.
[39] Bariya, S. H., Gohel, M. C., Mehta, T. A., 2012, "Microneedles: An Emerging Transdermal
Drug Delivery System," Journal of Pharmacy and Pharmacology, 64(1) pp. 11-29.
[40] Yang, N., Burkholder, J., Roberts, B., 1990, "In Vivo and in Vitro Gene Transfer to
Mammalian Somatic Cells by Particle Bombardment," Proceedings of the National Academy of
Sciences of the United States of America, 87(24) pp. 9568-9572.
[41] Gómez-Chiarri, M., Livingston, S. K., Muro-Cacho, C., 1996, "Introduction of Foreign
Genes into the Tissue of Live Fish by Direct Injection and Particle Bombardment," Diseases of
Aquatic Organisms, 27pp. 5-12.
[42] Shalek, A. K., Robinson, J. T., Karp, E. S., 2010, "Vertical Silicon Nanowires as a
Universal Platform for Delivering Biomolecules into Living Cells," Proceedings of the National
Academy of Sciences of the United States of America, 107(5) pp. 1870-1875.
105

[43] Kim, W., Ng, J. K., Kunitake, M. E., 2007, "Interfacing Silicon Nanowires with Mammalian
Cells," Journal of the American Chemical Society, 129(23) pp. 7228-7229.
[44] McKnight, T. E., Melechko, A. V., Griffin, G. D., 2003, "Intracellular Integration of
Synthetic Nanostructures with Viable Cells for Controlled Biochemical Manipulation,"
Nanotechnology, 14(5) pp. 551-556.
[45] VanDersarl, J. J., Xu, A. M., and Melosh, N. A., 2012, "Nanostraws for Direct Fluidic
Intracellular Access," Nano Letters, 12(8) pp. 3881.
[46] Park, S., Kim, Y., Kim, W. B., 2009, "Carbon Nanosyringe Array as a Platform for
Intracellular Delivery," Nano Letters, 9(4) pp. 1325.
[47] Lau, K. K. S., Bico, J., Teo, K. B. K., 2003, "Superhydrophobic Carbon Nanotube Forests,"
Nano Letters, 3(12) pp. 1701-1705.
[48] F. H.H. Gojny, M H G Wichmann, 2004, "Gojny, F.H., Et Al.: Carbon NanotubeReinforced Epoxy-Composites:Enhanced Stiffness and Fracture Toughness at Low Nanotube
Content. Compos. Sci. Technol. 64, 2363-2371," Composites Science and Technology, 64(15)
pp. 2363-2371.
[49] Yang, W., Thordarson, P., Gooding, J. J., 2007, "Carbon Nanotubes for Biological and
Biomedical Applications," Nanotechnology, 18(41) pp. 412001.
[50] Lim, H. D., Park, K. Y., Song, H., 2013, "Enhanced Power and Rechargeability of a LiO2
Battery Based on a Hierarchical-Fibril CNT Electrode," Advanced Materials, 25(9) pp. 13481352.
[51] Li, L., Yang, H., Zhou, D., 2014, "Progress in Application of CNTs in Lithium-Ion
Batteries," Journal of Nanomaterials, 2014pp. 1-8.
[52] Wang, X. H., Sun, L. N., Susantyoko, R. A., 2014, "Ultrahigh Volumetric Capacity Lithium
Ion Battery Anodes with CNT-Si Film," Nano Energy, 8pp. 71-77.
[53] O'Connell, M., Wisdom, J. A., Dai, H., 2005, "Carbon Nanotubes as Multifunctional
Biological Transporters and Near-Infrared Agents for Selective Cancer Cell Destruction,"
Proceedings of the National Academy of Sciences of the United States of America, 102(33) pp.
11600-11605.
[54] Khawli, L. A., and Prabhu, S., 2013, "Drug Delivery Across the Blood-Brain Barrier,"
Molecular Pharmaceutics, 10(5) pp. 1471.
[55] Harrison, B. S., and Atala, A., 2007, "Carbon Nanotube Applications for Tissue
Engineering," Biomaterials, 28(2) pp. 344-353.

106

[56] Kohli, P., and Martin, C. R., 2003, "The Emerging Field of Nanotube Biotechnology,"
Nature Reviews Drug Discovery, 2(1) pp. 29-37.
[57] Wang, J., 2005, "Carbon‐nanotube Based Electrochemical Biosensors: A Review,"
Electroanalysis, 17(1) pp. 7-14.
[58] Li, J., Ng, H. T., Cassell, A., 2003, "Carbon Nanotube Nanoelectrode Array for
Ultrasensitive DNA Detection," Nano Letters, 3(5) pp. 597-602.
[59] Brigger, I., Dubernet, C., and Couvreur, P., 2002, "Nanoparticles in Cancer Therapy and
Diagnosis," Advanced Drug Delivery Reviews, 54(5) pp. 631-651.
[60] Cherukuri, P., Gannon, C. J., Leeuw, T. K., 2006, "Mammalian Pharmacokinetics of Carbon
Nanotubes using Intrinsic Near-Infrared Fluorescence," Proceedings of the National Academy of
Sciences of the United States of America, 103(50) pp. 18882-18886.
[61] Singh, R., Pantarotto, D., Lacerda, L., 2006, "Tissue Biodistribution and Blood Clearance
Rates of Intravenously Administered Carbon Nanotube Radiotracers," Proceedings of the
National Academy of Sciences of the United States of America, 103(9) pp. 3357-3362.
[62] Saltzman, W. M., and Olbricht, W. L., 2002, "Building Drug Delivery into Tissue
Engineering," Nature Reviews. Drug Discovery, 1(3) pp. 177-186.
[63] Abarrategi, A., Gutiérrez, M. C., Moreno-Vicente, C., 2008, "Multiwall Carbon Nanotube
Scaffolds for Tissue Engineering Purposes," Biomaterials, 29(1) pp. 94-102.
[64] Yang, N., Chen, X., Ren, T., 2015, "Carbon Nanotube Based Biosensors," Sensors and
Actuators B: Chemical, 207pp. 690-715.
[65] Gelain, F., 2008, "Novel Opportunities and Challenges Offered by Nanobiomaterials in
Tissue Engineering," International Journal of Nanomedicine, 3(4) pp. 415-424.
[66] Che, G., Lakshmi, B. B., Martin, C. R., 1998, "Chemical Vapor Deposition Based Synthesis
of Carbon Nanotubes and Nanofibers using a Template Method," Chemistry of Materials, 10(1)
pp. 260-267.
[67] Xu, J., Zhang, X., Chen, F., 2005, "Preparation and Modification of Well-Aligned CNTs
Grown on AAO Template," Applied Surface Science, 239(3) pp. 320-326.
[68] Williams, K. R., Gupta, K., and Wasilik, M., 2003, "Etch Rates for Micromachining
Processing-Part II," Journal of Microelectromechanical Systems, 12(6) pp. 761-778.
[69] Zhou, B. R., W.F, 1996, "Kinetics and Modeling of Wet Etching of Aluminum Oxide by
Warm Phosphoric Acid," Journal of the Electrochemical Society, 143(2) pp. 619.

107

[70] Guofeng Hu, Haiming Zhang, Wenwen Di, 2009, "Study on Wet Etching of AAO
Template," Applied Physics Research, 1(2) pp. 78.
[71] Xiao, Z. L., Han, C. Y., Welp, U., 2002, "Fabrication of Alumina Nanotubes and Nanowires
by Etching Porous Alumina Membranes," Nano Letters, 2(11) pp. 1293-1297.
[72] Kim, N. H., Kim, D. S., Lee, H. U., 2007, "Fabrication of Microchannel Containing
Nanopillar Arrays using Micromachined AAO (Anodic Aluminum Oxide) Mold,"
Microelectronic Engineering, 84(5) pp. 1532-1535.
[73] Jee, S. E., Lee, P. S., Yoon, B., 2005, "Fabrication of Microstructures by Wet Etching of
Anodic Aluminum Oxide Substrates," Chemistry of Materials, 17(16) pp. 4049-4052.
[74] Lee, K. H., Huang, Y. P., and Wong, C. C., 2011, "Nanotip Fabrication by Anodic
Aluminum Oxide Templating," Electrochimica Acta, 56(5) pp. 2394-2398.
[75] Park, S., Kim, Y., Kim, W. B., 2009, "Carbon Nanosyringe Array as a Platform for
Intracellular Delivery," Nano Letters, 9(4) pp. 1325.
[76] Nojiri, K., and SpringerLink (Online service), 2014, "Dry Etching Technology for
Semiconductors," Springer International Publishing, Cham, .
[77] Anonymous "Electroporation," 2016.
[78] https://commons.wikimedia.org/w/index.php?curid=350191, "Chirality of Carbon
Nanotube," Public Domain.

108

